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Abstract 
 
CHARACTERIZATION OF THE NSPS-MBAA SIGNALING SYSTEM CONTROLLING 
BIOFILM FORMATION FROM POLYAMINE INPUT TO PHENOTYPIC OUTPUT 
 
Richard Charles Sobe 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
 
Chairperson: Ece Karatan 
 
 
 Biofilm formation is an important aspect of bacterial persistence in challenging 
environments. The bacterial pathogen, Vibrio cholerae, is an excellent biofilm former and 
this lifestyle has been implicated as playing a critical role in the pathogenicity of this 
microbe. Among the wide array of environmental signals that control V. cholerae biofilm 
formation are a select set of polyamines, norspermidine and spermidine. Norspermidine has a 
positive influence on biofilm formation while spermidine has the opposite effect, and these 
influences have been shown previously to occur through a signaling system comprised of the 
periplasmic binding protein, NspS, and the transmembrane phosphodiesterase, MbaA. In the 
absence of NspS, MbaA acts as a phosphodiesterase cleaving the pro-biofilm second 
messenger, cyclic di-GMP, indicating that NspS may interact with and inhibit 
phosphodiesterase activity and biofilm repression by MbaA. Recent work has shown that 
mutation of conserved amino acids in the proposed ligand-binding pocket of NspS results in 
drastic alterations of biofilm phenotypes. However, the exact mechanism underlying these 
influences remained to be elucidated and the capacity of these mutants to support polyamine 
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signaling had not been investigated. In this study, I have shown that several nspS binding 
pocket mutants have altered sensitivity to norspermidine and spermidine as indicated by vps 
transcription and biofilm assays. I have also shown using thermal shift assays that all of these 
mutants are capable of binding both polyamines. LC-MS/MS analyses indicate that the 
NspS-MbaA signaling pathway is a high specificity c-di-GMP signaling system. 
Additionally, a system for reproducible demonstration of the NspS-MbaA interaction was 
developed which may subsequently be used in future experiments to study the NspS and 
MbaA interaction and also to identify an MbaA-interaction surface on NspS. Altogether, this 
study provides a thorough investigation of the steps involved in polyamine signal input to 
phenotypic output for a novel polyamine responsive signaling system controlling biofilm 
formation. 
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Introduction 
 
 
Biofilms 
Bacterial biofilms are communities of bacteria encased in an exopolymeric substance 
(EPS) consisting primarily of exopolysaccharide, protein, and DNA [1-3]. Biofilms are 
ubiquitous in nature where these structures may form anchored to surfaces including 
exoskeleton of aquatic crustaceans, rocks, and glass, at liquid-air interfaces, or independently 
of surfaces in the form of flocs [4, 5]. In aquatic environments biofilms are often 
heterogeneous, and complex intercellular interactions mediate the relative composition of a 
variety of bacterial species [6, 7]. Symbiotic relationships also exist between biofilm forming 
bacteria and macroorganisms as is the case for sepiolid squid which, just hours after 
hatching, is colonized by Vibrio fischeri within crypts of the light organ [8]. The light organ 
provides an environment conducive for rapid bacterial cell proliferation, and at high cell 
densities, the V. fischeri community induces luciferase production at this site to aid in 
predation avoidance by squid in the form of counterillumination. Additionally, bacterial 
biofilms may be pathogenic as is the case for those formed on human teeth in the form of 
dental caries, within the lungs of cystic fibrosis patients by Pseudomonas aeruginosa, or at 
the site of surgical pin implants or catheter entry [5, 9]. Finally, in many aquatic systems, 
bacterial biofilms play a principal role in energy flow in nutrient cycling [10, 11]. 
Biofilm formation is a multi-step process which typically begins with transient 
attachments by planktonic bacteria at a surface, followed by permanent attachment to form a 
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monolayer, given the appropriate positive cues [6, 7]. Maturation of the biofilm occurs 
through further recruitment of other planktonic bacteria, as well as cell division by current 
members to form mushroom-like pillars of bacteria encased in EPS [12, 13]. The mature 
biofilm is characterized by a matrix of EPS-encrusted bacteria forming water-filled channels 
through which dissipation of waste and circulation of environmentally acquired nutrients is 
permitted [14, 15]. At this stage, some bacteria in the biofilm may detach in an attempt to 
colonize new surfaces or environments. Once established, the biofilm serves as a defensive 
unit for inhabitants by shielding and/or diminishing the effects of a multitude of stressors 
including UV radiation, osmotic and oxidative stress, predation, and antimicrobials [16-19]. 
Additionally, the complex structure of the biofilm permits communication between 
inhabitants as water-filled channels permit flow of intercellular signaling cues [15]. Finally, 
biofilms offer the additional advantage of increased environmental persistence exemplified 
by the pathogenic Shiga toxin-producing Escherichia coli biofilms formed in meat 
processing plants which have increased resistance against biocidal agents and sanitizers 
including quaternary ammonium compounds, peroxyacetic acid, and chlorine compounds 
[20]. 
Vibrio cholerae and cholera 
 Another example of a bacterium which uses biofilms to maintain environmental 
persistence is the human pathogen, Vibrio cholerae. This bacterium is a natural inhabitant of 
aquatic ecosystems including oceans, lakes, rivers, and estuaries, and is an endemic pathogen 
and causative agent of the disease cholera in Africa, Asia, India, and most recently, Haiti [21, 
22]. Cholera outbreaks typically occur in a seasonal fashion with case numbers typically 
peaking following monsoons, and with warm sea surface temperatures associated with the 
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Spring and plankton blooms [23-25]. Exemplifying the capacity of V. cholerae to colonize 
and persist in new environments once introduced is the case of the cholera outbreak in Haiti 
which has continued for over five years. Indeed, cholera cases had not been reported in Haiti 
since the 1960’s; however, since at least one UN worker reportedly contaminated Haitian 
water sources with V. cholerae during relief efforts for the 2010 earthquake, over 700,000 
cases of cholera have been reported [26, 27]. Interestingly, a recent study showed that during 
a 2005 epidemic in Dhaka, peak levels of cholera cases were preceded by peak levels of V. 
cholerae serogroup O1 in a variety of environmental water sources, which in turn was 
followed by elevated levels of a lytic cholera bacteriophage, JSF4, in patient stool and water 
systems. This phage has been shown to produce a heat labile toxin with bacteriocidal effects 
on V. cholerae and may thus serve to limit cholera outbreaks and epidemics in its native 
waters, thus potentially providing options for phage-based treatment of water sources [24].  
 During interepidemic periods, V. cholerae has been shown to persist in aquatic 
environments by forming biofilms on a variety of aquatic organisms including chitinous 
crustaceans, plankton, copepods, insects, and aquatic plants [28-31]. V. cholerae has also 
been isolated from the feet and feathers of water fowl which may provide a conduit for 
colonization of otherwise uncontaminated water sources [31]. Cholera is often caused by 
consumption of contaminated drinking water and aquatic food sources [31, 32]. While the 
infectious dose of free swimming or planktonic organisms in healthy individuals is 
approximately 10
3
-10
8
, that of biofilm-associated organisms is orders of magnitude lower 
due to protection of the biofilm from the acidic environment of the stomach [33-35]. 
Additionally, the increased cell density of a biofilm as compared to planktonic counterparts 
enhances the infectious capacity of the former [36]. Following passage of V. cholerae 
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through the stomach and into the lower intestine, a variety of host factors trigger biofilm 
degradation and upregulation of virulence properties including those necessary for intestinal 
colonization, the toxin co-regulated pilus (TCP) and cholera toxin (CT) [34, 37]. TCP is 
required for intestinal colonization and permits non-biofilm cell aggregation and attachment 
to the intestinal epithelial crypts while CT causes cAMP dysregulation of intestinal cells 
resulting in efflux of chloride ions and water [32, 38]. This efflux results in the characteristic 
massive diarrhea and vomiting of cholera patients which leads to dehydration, and eventually 
death of the host if not promptly treated with rehydration therapy and replenishment of 
electrolytes [39]. Importantly, V. cholerae present in the stool of cholera patients are 
especially virulent [34]. Interestingly, biofilm components have also been detected in the 
stool of cholera patients indicating that, while a motile form of V. cholerae is required for 
virulence factor production, biofilm-associated cells may also be present within the intestine 
during infection [34, 38]. 
c-di-GMP metabolism 
 The principal regulator of biofilm formation is the cyclic di-nucleotide, bis-(3’-5’) 
cyclic dimeric GMP, or c-di-GMP. The molecule was first discovered in Gluconacetobacter 
xylinus and determined to play a role in cellulose synthesis in this organism [40]. It has since 
been recognized as the key second messenger controlling a variety of phenotypes and 
processes including virulence, intracellular signaling, and cell-cycle progression [40, 41]. C-
di-GMP is generated from two molecules of guanosine triphosphate (GTP) by enzymes 
known as diguanylate cyclases (DGC) with conserved GGDEF domains, and degraded to 
pGpG or guanosine monophosphate (GMP) by phosphodiesterases (PDE) with EAL or HD-
GYP domains, respectively [42]. These domains are named for conserved amino acids which 
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have been shown to provide the enzymatic activity required for c-di-GMP metabolism. The 
catalytic domains are often linked to sensory domains involved in monitoring environmental 
as well as intracellular signals to control enzymatic activity. Some of the signals shown to 
modulate c-di-GMP turnover activity include molecular oxygen, amino acids, blue light, 
polyamines, and quorum sensing signals [43-45]. These substances typically interact with 
membrane protein domains exposed on the exterior of the cytoplasmic membrane, with 
periplasmic binding proteins, or directly influence intracellular proteins. The receptors may 
in turn directly metabolize c-di-GMP in the cytoplasm, interact with other proteins 
responsible for c-di-GMP metabolism, and/or initiate protein signaling cascades to control 
relative levels of c-di-GMP metabolizing proteins. 
Many organisms produce large numbers of c-di-GMP-metabolizing enzymes. This 
observation is exemplified by the V. cholerae genome which encodes over 60 c-di-GMP-
metabolizing proteins [46]. Elucidating the mechanisms, roles, and contribution of these 
proteins towards lifestyle-mediating decisions in various organisms has thus been the focus 
of many studies in the last two decades [40, 47-54]. With regards to c-di-GMP synthesis, 
functional DGCs usually have a conserved C-terminal GG(D/E)EF amino acid motif within 
the enzymatic domain as well as variable N-terminal domains involved in signal recognition 
[54]. Interestingly, a novel protein called VCA0965 in Vibrio cholerae was recently shown to 
have DGC activity despite having a GGDEF motif variant, AGDEF, in the active site, 
indicating that deviations from this conserved motif can sometimes be tolerated [52]. In 
1987, the same year c-di-GMP was discovered, Benziman and colleagues showed that 
cyclization of two GTP molecules proceeds in a two-step reaction whereby each 
phosphodiester bond is formed following the release of pyrophosphate [55]. The catalytic 
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domain containing the GGDEF motif, called the active or A site, is the point of GTP docking 
[56]. To accommodate for the symmetric nature of cyclic dinucleotides, DGC domains form 
homodimers with the A sites facing one another in antiparallel orientation to facilitate the 
sequential enzymatic formation of phosphoester bonds through deprotonation of GTP 3’ OH 
groups followed by nucleophilic attack at each α-phosphate [56, 57]. In contrast to the related 
adenylyl cyclases (AC), this dimerization is an apparent necessity for maximum catalytic 
activity [56]. The conserved GG(D/E)EF motif is believed to form a β-hairpin where both 
glycines in the GGDEF motif interact with the guanine base as well as with the β- and γ-
phosphates while the glutamate residue coordinates either Mn
2+
 or Mg
2+
 cations required for 
activity [54, 56]. The third amino acid in the motif (Asp/Glu) is also believed to direct metal 
binding.  Following release of the first pyrophosphate, a 5’-pppGpG intermediate is formed 
before the second round of GTPase activity occurs and the second phosphoester bond is 
formed resulting in the final c-di-GMP product. Interestingly, it has been shown that purified 
GGDEF domains form homodimers which tend to have low level DGC activity in vitro [58]. 
However, it is hypothesized that only small conformational changes occur in the A site of 
each homodimer subunit during c-di-GMP synthesis suggesting that the catalytic domains (if 
not entire monomers) remain separated until otherwise preventative regulatory mechanisms 
allow for an interaction to occur following recognition of a ligand/signal by the sensory 
domain [58]. Phosphorylation-mediated activation of response regulator (RR) DGCs by 
cognate sensor histidine kinases (HK) has been implicated as the most common route for 
formation of catalytically active homodimers [56]. 
Degradation of c-di-GMP in bacteria is achieved through PDE activity of proteins 
containing domains with conserved EAL or HD-GYP motifs [54]. The EAL domain proteins 
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hydrolyze c-di-GMP to 5’-pGpG and require two Mn
2+
 or Mg
2+
 molecules for catalytic 
activity [59]. While EAL domain proteins have been shown to break down 5’-pGpG further 
to two molecules of GMP, the rate of hydrolysis is much lower [60]. Similar to DGCs, EAL 
domain PDE dimer formation appears necessary for activation by environmental stimuli in 
vitro. Interestingly these PDEs may also form larger oligomers and show only reduced 
activity as monomers in vitro [60, 61]. Further degradation to pG (GMP) is performed by a 
Ca-independent enzyme. Many EAL PDEs retain some catalytic activity as monomers [54]. 
However, for EAL proteins to become fully active, they dimerize in an antiparallel fashion 
with associative interactions occurring through one α-helix from each catalytic domain and a 
third formed by joining two short helices from each domain [62]. When c-di-GMP enters the 
active site of PDE dimers, it assumes an extended or “open” shape such that phosphoester 
cleavage is favored. Two metal cation catalytic clusters are responsible for coordinating two 
water molecules in the EAL active site [62]. One of these water molecules is involved in the 
phosphoester bond cleavage. Optimum conditions occur at higher pH using Mn
2+
 while less 
optimal conditions occur with low pH and Mg
2+
 cations. Upon stimulation, conformational 
changes in the sensory domain impart proximity adjustments at the interface of the dimerized 
catalytic domain interface and in turn coordinate the metal-water cluster for optimal 
hydrolysis of c-di-GMP via nucleophilic attack at the phosphorus atom [62].  
The second class of PDEs contains a conserved HD-GYP motif. Shortly after their 
discovery, these proteins were predicted to have c-di-GMP-specific hydrolytic function based 
on the proximity of these conserved domains to GGDEF domains which resembled the 
tandem GGDEF-EAL trend seen in many bacteria [54]. In support of this, it was shown by 
Ryan and colleagues that HD-GYP could compliment an EAL domain mutant and was 
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shown to specifically degrade c-di-GMP in vitro [63]. However, in contrast to EAL proteins, 
the final product of c-di-GMP catabolism is two molecules of GMP with pGpG as an 
intermediate [63]. The crystal structures of several active HD-GYP domain proteins were 
recently solved including Bd1817 from Bdellovibrio bacteriovorus and PmGH from 
Persephonella marina [64]. It has been shown that these proteins are arranged facing one 
another with three iron ions arranged in a triangle to form the active site [65]. The HD 
portion of the motif was shown in particular to bind iron in the active site. The c-di-GMP 
molecule takes on a ‘U’ shape with the phosphates, located at the bend, interacting with the 
central iron molecule which in turn allows for a conserved aspartate residue to remove a 
proton from a neighboring water molecule leaving a hydroxide to make a nucleophilic attack 
on each phosphorus leaving two molecules of GMP [66]. Some HD-GYP domain-containing 
proteins have masked catalytic domains prior to activation. One example is PA4781 from P. 
aeruginosa which is catalytically inactive in the unphosphorylated state potentially due to 
veiling of the enzymatic motif by its REC domain [66]. 
Regulation of Vibrio cholerae biofilms by c-di-GMP 
In Vibrio cholerae biofilms, the EPS consists primarily of Vibrio polysaccharide 
(VPS) whose synthesis is controlled through regulation of the vps genes [67]. The vps genes 
encode proteins that consist of structural and regulatory components of V. cholerae VPS. 
Transcription of these genes is controlled by the positive transcriptional regulators of biofilm 
formation, VpsT and VpsR [68]. The vps genes are clustered in two operons, vpsA-K and 
vpsL-Q [69]. A variety of signals influence vps transcription, and thus V. cholerae biofilm 
formation, including quorum sensing (QS) molecules, environmental stressors, and 
nutritional information [70]. These signals feed into a complex network of interconnected 
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pathways including but not limited to quorum sensing and c-di-GMP-mediated pathways 
which ultimately influence vps gene transcription. Downstream signaling culminates in 
modulation of intracellular concentrations of c-di-GMP to regulate biofilm formation via 
modulation of vps gene expression [54]. c-di-GMP acts at transcriptional, post-translational, 
and allosteric levels to maintain stringent control of transitions to and from motile and sessile 
lifestyles [40]. 
 The QS pathway negatively regulates biofilm formation in V. cholerae via sensing of 
extracellular concentrations of two self-produced and secreted signaling molecules, cholera 
autoinducer -1 (CAI-1) and AI-2 [37]. At low cell density, and thus low autoinducer (AI) 
concentrations, sensory histidine kinases (HK) CpqS and LuxPQ are unbound to their 
respective AI’s and act as kinases (Figure 1). Kinase activity results in phosphorylation of the 
histidine phosphotransferase (HPT) protein, LuxU (not shown), which in turn mediates 
phosphorylation of the response regulator (RR), LuxO [71]. LuxO is a σ
54
-dependent 
transcriptional activator which, in its phosphorylated state, activates transcription of four 
redundant small regulatory RNAs (sRNA), Qrr1-4. These sRNAs act together with the small 
RNA chaperone Hfq to destabilize the mRNA of QS master regulator, HapR. At high cell 
density, CqsS and LuxQ are bound to CAI-1 and AI-2, respectively, and act as phosphatases 
resulting in HapR production [71]. HapR contains a DNA-binding motif and acts as a 
negative regulator of biofilm formation by modulating transcription of 14 DGC- and PDE-
encoding genes in response to environmental cues [72]. Furthermore, HapR directly binds 
and decreases transcription of vpsR and vpsT genes encoding the positive regulators of 
biofilm formation, VpsT and VpsR. In addition, HapR negatively influences biofilm 
formation through direct binding of both vps operon promoters [1, 32]. 
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Figure 1: Quorum sensing-dependent regulation of biofilm formation. At low cell 
density and thus low AI concentrations, LuxPQ and CpqS remain unbound to their respective 
AIs, AI-2 and CAI-1, and act as kinases phosphorylating LuxO. LuxO activates Qrr sRNA 1-
4 transcription which destabilizes hapR mRNA and permits DGC activity by GGDEF 
proteins allowing for accumulation of c-di-GMP (red triangles), and activation of VpsR and 
VpsT leading to increased biofilm formation. At high cell density, phosphoryl flow is 
reversed and Qrr sRNA is not made permitting HapR translation. HapR differentially 
regulates transcription of several DGCs and PDEs leading to reductions in c-di-GMP. 
Simultaneously, HapR represses VpsR and VpsT to inhibit vps transcription and thus biofilm 
formation. Adapted from [72]. 
 
The vps operons are under tight regulation and are controlled primarily by quorum 
sensing and fluctuations in intracellular c-di-GMP. Elevated levels of c-di-GMP activate 
VpsT and VpsR by binding these proteins. VpsT and VpsR then increase their own gene 
transcription as well as that of one another, several DGCs, and the vps genes [1]. Indeed, 
VpsR contains a helix-turn-helix (HTH) DNA-binding domain which, upon c-di-GMP-
dependent activation, binds upstream of the vpsT promoter from base pair (bp) -136 to -118 
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in a σ
54
-dependent manner [43]. In support of this, Casper et al. showed that VpsT expression 
requires VpsR [73]. However, QS inputs take precedence over c-di-GMP influences on 
biofilm formation as, at high cell density, QS master regulator HapR blocks vpsT gene 
transcription via binding upstream of the vpsT promoter in a region that overlaps the DNA-
binding site of VpsR (bp -144 to -123) [43]. The same study elucidated a similar mechanism 
of transcriptional control for the activator of virulence gene expression, aphA, suggesting this 
may be a common theme for integrating QS- and c-di-GMP-mediated control of VPS 
production and virulence gene regulation [43].  
While both VpsT and VpsR positively regulate VPS production, VpsR has the 
greatest impact on vps gene transcription [1]. Beyhan et al. showed that vpsL expression is 
undetectable in a vpsR single mutant or vpsRhapR double mutant and vpsA is transcribed at 
significantly lower levels as compared to that in a vpsT mutant [1]. Gene expression 
profiling, qRT-PCR, biofilm assays, and colony morphology analysis of V. cholerae mutants 
harboring all possible combinations of single, double, and triple deletion mutants of vpsT, 
vpsR, and hapR were used to generate a model for QS and c-di-GMP-mediated control of 
biofilm formation [1]. An epistasis model for VpsT-, VpsR-, and HapR-mediated biofilm 
formation has been proposed (Figure 2). As mentioned above, VpsT and VpsR positively 
regulate their own transcription as well as that  
of one another. In addition, both proteins positively regulate transcription of the DGC, CdgA, 
and vps genes, and negatively regulate HapR. Notably, VpsR increases cdgA and vps gene 
transcription at a greater magnitude than VpsT [1]. In contrast, HapR negatively regulates 
transcription of VpsT, VpsR, CdgA, and vps genes as well as its own transcription. 
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Though not required for biofilm formation, a histidine sensor kinase, VpsS, enhances 
biofilm formation and overexpression of VpsS results in more robust biofilms as compared to 
strains expressing the same at wild type levels [74]. VpsS indirectly increases vpsT and vpsR 
gene transcription by funneling a phosphoryl group through the HPT and RR components of 
the QS circuit LuxU and LuxO, respectively. Activated LuxO then binds the promoter 
regions of vpsT and vpsR to increase their gene transcription [74]. 
 
 
Effect of polyamines on V. cholerae biofilm formation 
Among the many signals known to alter V. cholerae biofilm formation through 
influences in vps gene transcription are polyamines; polycationic aminated hydrocarbons. 
Polyamines play important roles in influencing an array of cellular processes and phenotypes 
including growth, virulence, iron sequestration, cell wall development, acid resistance, and 
biofilm formation [75, 76]. The triamine norspermidine has been shown to enhance biofilm 
Figure 2: Biofilm formation is controlled by a complex network of transcriptional 
regulators. VpsT and VpsR positively regulate their own transcription, the transcription of 
one another, CdgA (a DGC), and that of the vps genes to increase biofilm formation. The 
contribution of VpsR to increases in CdgA and VPS gene transcription is greater than that 
of VpsT. The master regulator of QS, HapR, downregulates vpsT, vpsR, cdgA, vps, and its 
own transcription to decrease VPS production and biofilm formation. Thicker lines 
indicate greater transcriptional impact of corresponding genes [1]. 
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formation in V. cholerae and is produced by a variety of aquatic organisms such as algae, 
bivalves, and plants [47, 77]. Additionally, while norspermidine is rarely produced by 
prokaryotes, V. cholerae is capable of synthesizing this polyamine which may thus serve as a 
V. cholerae-specific autoinducer signal [78]. Another triamine produced both by the host and 
human gut microbiota known as spermidine has been shown to inhibit biofilm formation in 
vitro  suggestive of a potential role in signaling entry into the intestine to prime the bacteria 
for virulence factor production [79]. These effects of both of these polyamines on biofilm 
formation are hypothesized to occur by acting through a signaling system comprised of the 
proteins, NspS, short for norspermidine sensor, and MbaA [80]. Importantly, although 
nspS/mbaA-like gene pairs are widespread in bacteria, the V. cholerae NspS-MbaA signal 
transduction system is the first polyamine signaling system to be characterized [81]. MbaA is 
a transmembrane protein anchored to the cytoplasmic membrane by two transmembrane 
helices and contains large cytoplasmic and periplasmic domains [5]. The cytoplasmic domain 
is composed of a C-terminal EAL domain and membrane-proximal GGDEF domain. While 
wild-type V. cholerae forms intermediate biofilms, ΔmbaA mutants form robust biofilms and 
ΔnspS mutants form very little biofilms indicating that MbaA acts as a PDE in the absence of 
NspS [80]. In support of these observations, purified MbaA protein consisting of the 
cytoplasmic GGDEF and EAL domain has c-di-GMP-specific PDE activity in vitro [81]. 
Importantly, prior to this study, the contribution of MbaA to cellular c-di-GMP pools had yet 
to be investigated. Additionally, the potential for DGC activity has not yet been investigated 
for the GGDEF domain; however, it is interesting to note that the canonical GGDEF motif is 
degenerate and encodes an altered SGDEF motif which may render this domain inactive [81]. 
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Future research will be required to determine if and how the GGDEF domain 1) interacts 
with c-di-GMP and 2) is capable of acting as a DGC. 
The periplasmic domain of MbaA is hypothesized to transmit periplasmic signals by 
NspS through the inner membrane to control c-di-GMP metabolism. NspS is a periplasmic 
binding protein (PBP) homologous to the PotD protein involved in polyamine transport in E. 
coli and V. cholerae [80]. NspS has been shown to bind the polyamines norspermidine and 
spermidine, but does not play a role in transport of either polyamine indicating a potential 
role in signaling through MbaA [81]. There is evidence for an interaction between these 
proteins; however, reproducible results have been difficult to obtain, perhaps due to low 
expression levels of nspS and mbaA and solubility issues common with membrane proteins 
(Brennan WB and Karatan E, unpublished data) [82, 83]. 
As mentioned above, norspermidine and spermidine have opposite effects on biofilm 
formation in a NspS- and MbaA-dependent manner and NspS is capable of binding both 
polyamines intro. Unpublished work from our lab has identified seven conserved amino acid 
residues located in the binding cleft of NspS which are involved in binding of the E. coli 
PotD protein to spermidine (Figure 3) [82]. PotD is a periplasmic ligand-binding protein of 
the ABC-type transporter responsible for importing spermidine in E. coli, and is homologous 
to NspS. Importantly, the amino acid sequence of NspS shares greater identity with that of 
PotF than with PotD. PotF is another polyamine-binding protein from E. coli. Therefore, 
PotF was used for homology modeling shown in Figure 3A. From the homology model, 
simulations were used to identify proximal amino acids within the putative NspS binding 
cleft with hand-docked norspermidine which were likely to have amino-aromatic or 
hydrogen bond interactions with the ligand (Figure 3B). Mutation of these residues results in 
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drastic alterations of V. cholerae biofilms (Figure 3C); however, it had not been shown what 
effects norspermidine and spermidine have on biofilms or vps transcription of ΔnspS mutants 
complemented with altered nspS genes. 
 
Figure 3. Conserved NspS binding pocket residues with a putative ligand-binding role 
influence biofilm formation. NspS homology model based off of the solved crystal structure 
of PotF (A). Conserved nspS binding pocket residues hypothesized to be involved in 
polyamine binding (B) were mutated and introduced into a ∆nspS mutant for comparison of 
biofilm formation to that of a strain expressing wild-type nspS when grown in LB media 
alone (C) [82]. 
 
The purpose of this study was to more thoroughly characterize the NspS-MbaA 
signaling system and its role in biofilm formation in response to norspermidine and 
spermidine. A current working model of this system composed of five points of transduction 
control from signal input to phenotypic output is proposed in Figure 4. In this model: 1) 
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norspermidine and/or spermidine in the environment enter the periplasm and interact with 
NspS, 2) NspS undergoes conformational changes which alter the interface between NspS 
and MbaA, 3) alterations at the NspS-MbaA interface modulate PDE activity in the 
periplasm to control c-di-GMP levels, 4) changes in intracellular c-di-GMP influence vps 
gene transcription, and 5) altered VPS production manifests in the form of altered biofilm 
formation.  
 
Figure 4: Schematic of the NspS-MbaA regulatory pathway. Polyamines such as 
norspermidine interact with NspS in the periplasm causing a conformational change at the 
NspS-MbaA interface to alter c-di-GMP PDE activity. Alterations in c-di-GMP influence 
exopolysaccharide gene expression and biofilm formation. Adapted from [5]. 
 
To further characterize the NspS-MbaA signaling system, ΔnspS mutants harboring 
altered nspS gene complements were investigated for their ability to alter vps gene 
transcription and biofilm formation in response to norspermidine and spermidine addition. 
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Additionally, binding of purified NspS mutant protein to norspermidine and spermidine was 
compared to that of wild-type NspS. Global c-di-GMP levels of an MbaA mutant were then 
quantified and compared to that of wild-type V. cholerae. Finally, a system for investigating 
the NspS-MbaA interaction as well as high through-put screening of NspS residues required 
for the interaction was developed. 
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Materials and Methods 
 
 
Bacterial strains, primers, plasmids, media, and reagents 
 The bacterial strains and plasmids are listed in Table 1 and primers in Table 2, 
respectively. All strains were grown on Luria-Bertani (LB) agar (1% Tryptone, 0.5% Yeast 
Extract, 85 mM NaCl, 1.5 % agar) containing appropriate antibiotics for 24 hours at 37°C 
prior to incubation in LB or tryptone broth (1% Tryptone, 0.5%, 85 mM NaCl) and 
antibiotics overnight at 37°C with shaking at 200 rpm unless otherwise noted. Primer 
synthesis was performed by Eurofins MWG Operon (Huntsville, AL). DNA sequencing was 
performed by Cornell University (Ithaca, NY) and Eurofins MWG Operon (Huntsville, AL). 
The restriction enzymes, XhoI, SpeI, NdeI, and SalI, and Phusion and OneTaq polymerases 
were purchased from New England Biofilms (Beverly, MA). The polyamines, cadaverine-
dihydrochloride, putrescine dihydrochloride, norspermidine, and spermidine-trihydrochloride 
were purchased from Sigma-Aldrich (St. Louis, MO). Chemicals and reagents were 
purchased from Alfa Aesar (Ward Hill, MA), Amresco (Solon, OH), Fischer Scientific 
(Fairlawn, NJ), Sigma-Aldrich (St. Louis, MI), or VWR (Radnor, PA) unless otherwise 
noted. 
Visualization of nspS mutant colony morphology 
 Bacteria were grown on LB agar plates supplemented with 2.5µg/mL tetracycline at 
27°C for 24 hours. Colonies were visualized at 25.6 x magnification using an Olympus ZX12 
stereozoom microscope connected to a SONY HDR-HC7 high definition digital camcorder. 
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Table 1: Bacterial strains and plasmids 
Strain Genotype Reference 
E. coli strains 
  
DH5α 
F– Φ80lacZΔM15 Δ(lacZYA-argF) 169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Invitrogen 
Shuffle® T7 
Express 
fhuA2 lacZ::T7 gene1 [lon] ompT ahpC gal λatt::pNEB3-r1-
cDsbC (Spec
R
, lacI
q
) ΔtrxB sulA11 R(mcr-73::miniTn10--Tet
S
)2 
[dcm] R(zgb-210::Tn10 --Tet
S
) endA1 Δgor ∆(mcrC-mrr)114::IS10 
New England Biolabs 
AK340 Shuffle (pET28b::nspSD170A) 
Gardzilla A, Karatan A 
Unpublished data 
AK350 Shuffle (pET28b::nspSW261A) 
Hoyle J, Karatan E 
Unpublished data 
AK352 Shuffle (ppET28b::nspSE173A) 
Wozniak J, Karatan E 
Unpublished data 
AK356 Shuffle (pET28b::nspS) [84] 
AK363 DH5α w/pCR2.1::mbaA-FLAG-0702 This study 
AK369 DH5α λ pir w/pWM91::mbaA-FLAG-0702 This study 
AK408 DH5α w/ pFLMp This study 
 
V. cholerae strains 
PW357 MO10, lacZ::vpsLp→ lacZ, Sm
r
 [80] 
PW444 MO10 ΔmbaA,lacZ::vpsLp→lacZ, Sm
r
 [80] 
PW514 MO10 ΔnspS,  lacZ::vpsLp→lacZ, Sm
r
 [80] 
PW522 MO10 ΔnspS,ΔmbaA,lacZ::vpsLp→lacZ, Sm
r
 [80] 
AK007 PW514 (pACYC184::nspS) [82] 
AK035 PW514 (pACYC184::nspSE173A) [82] 
AK070 PW514 (pACYC184::nspSD170A) [82] 
AK075 PW514 (pACYC184::nspSW261A) [82] 
AK192 PW514 (pACYC184::nspS) [83] 
AK193 PW522 (pACYC184::nspS) This study 
AK416 522 (pFLMP and pNP1) This study 
AK426 522 (pFLAG and pNP1) This study 
AK442 522 (pFLMP and pACYC184) This study 
 
Plasmids 
pCR2.1-TOPO Plasmid for TOPO cloning, Ampr Invitrogen 
pFLAG-CTC Amp Sigma-Aldrich 
pCRMP pCR2.1::nspSss-mbaAperi This study 
pFLMP pFLAG::nspSss-mbaAperi This study 
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Table 2: Primers used in this study. 
Primer Description Sequence 
PA228 
Forward primer for amplifying the "up" fragment of 
chomosomal mbaA-FLAG-0702 
TTGCTGCACGAACTCTCGCG 
PA229 
Reverse primer for amplifying the "up" fragment of 
chomosomal mbaA-FLAG-0702 
CTTATCGTCGTCATCCTTGTAAT 
CACGGCATTCACTTTGGCTGGG 
PA230 
Forward primer for amplifying the "down" fragment of 
chomosomal mbaA-FLAG-0702 
GATTACAAGGATGACGACGATA 
AGTAGAAGTGCCTTTAGCACCG 
PA231 
Reverse primer for amplifying the "down" fragment of 
chomosomal mbaA-FLAG-0702 
CTGTGCTGCGGGTGAGATGG 
PA234 
Reverse FLAG sequence primer to verify 
homologous recombination of mbaA-FLAG-0702 
GGCTTCTACTTTGGTTATCC 
PA235 
Forward FLAG sequence primer to verify 
homologous recombination of mbaA-FLAG-0702 
GGTTTCCTCGTCACTCAT 
PA238 N26 - pFLAG-CTC forward vector primer 
CATCATAACGGTTCTGGCAAATA 
TTC 
PA239 C24 - pFLAG-CTC reverse vector primer CTGTATCAGGCTGAAAATCTTCTC 
PA253 
Encodes NspS signal sequence plus six nucleotides 
for signal peptidase recognition  with 5' NdeI site 
CCGCCGCCATATGACCAATTTTT 
GTAACGAATGGGTATCGTATTCAC 
AAATGATCAAACGCTTTCTGTCGC 
TGATGGTATTGAATACTGTCTGTT 
ATCAAGCCAGCGCTTTGGAA 
PA254 Forward primer for nspS signal sequence CCGCCGCCATATGACCAA 
PA255 Forward primer for mbaA periplasmic sequence 
GTTATCAAGCCAGCGCTTTGGAA 
ACCAGTCAGAAAAATGCGCTGCT 
AA 
PA256 Reverse primer for mbaA periplasmic sequence 
GTCGACTTCGCGCTGAATGGAG 
TGAAGC 
 
Biofilm assays 
 Overnight cultures were diluted 1:50 in fresh media (tryptone or LB) broth containing 
appropriate antibiotics and grown to mid-log phase at 27°C with shaking at 200 rpm. Once at 
mid-log phase, 1.5 mL of culture was pelleted and cells were resuspended in 150 μl fresh 
media. Fresh cultures were inoculated at a final OD595 of 0.04 in 300 μl fresh media only or 
media containing 10 μM, 100 μM, or 1 mM norspermidine or spermidine in borosilicate 
tubes. Biofilms were formed under static conditions for 48 hours at 27°C. One hundred and 
fifty μL of the planktonic cells were transferred to a 96-well plate for OD595 measurements. 
Biofilms were washed in 300 μL PBS and the wash was discarded. A small amount of glass 
beads and 300 μL PBS were added, and biofilms were sheared by vortexing for 30 seconds. 
Biofilm cell densities were quantified by measuring 150 μL of homogenous biofilm cell 
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suspension at OD595 in a 96-well plate. Statistical analysis was performed using two-way 
ANOVA through Sigma Plot. 
vps gene transcription assays 
vpsL promoter activity of ∆nspS mutants harboring a pACYC184 plasmid containing 
nspS binding pocket mutants (nspSD170A, nspSE173A, and nspSW263A), or empty vector was 
compared to the same expressing wild type nspS in the presence and absence of spermidine 
by making use of a vpsLp-lacZ fusion in these strains. Importantly, the yeast extract of LB 
media contains variable levels of spermidine and thus tryptone media was chosen as the 
growth medium of liquid cultures in these experiments as it contains negligible amounts of 
spermidine (approximately 3-4 µM) (Sanders, BE and Karatan, E., unpublished data). 
Isolated colonies were inoculated in 2 mL tryptone media containing 100 µg/mL 
streptomycin and grown overnight at 27°C with shaking at 200 rpm. Day cultures were 
grown from overnight cultures diluted to an OD595 of 0.04 in fresh tryptone media in the 
presence or absence of 100 µM norspermidine or 1 mM spermidine. Once mid-log phase was 
reached, the OD595 was measured for standardization purposes and 1 mL of each culture was 
pelleted at 16,100 x g. Pellets were washed in 1 mL Z-buffer and repelleted [47]. Washed 
pellets were frozen at -20°C for at least 30 minutes, resuspened in 200 ul Z-buffer containing 
2.7 ul/mL β-mercaptoethanol and 20 uL/mL protease inhibitors and thawed (Sigma-Aldrich, 
St. Louis, MO). Cells were kept cold in an ice block for the following lysis steps. Lysis was 
completed by three rounds of sonication on ice with a duty cycle of 30% and microtip output 
control of 3 for 10 seconds each. Cell debris was pelleted for 2 minutes at 16,100 x g and 
lysates were incubated with 40 µL of 4 mg/mL o-nitrophenyl-β-D-galactoside (ONPG) 
substrate at 37°C until a yellow color change was observed indicating presence of the 
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breakdown product of ONPG, o-nitrophenol. The OD415 was determined for 150 µL of the 
lysate-substrate mixture. Equation (1) was used to calculate Miller Units of β-galactosidase 
activity. Statistical analysis was performed using two-way ANOVA through Sigma Plot. 
 Miller Units = 1000*OD595*(t*v*OD415)
-1  
1 
Where: 
OD595 = Optical density of cultures 
OD415 = Optical density of reaction mixture 
t = time of reaction in minutes 
v = reaction volume in mL 
Purification of wild-type NspS and mutants 
 Overnight cultures were grown from isolated colonies resuspended in 50 μl LB broth 
inoculated into 20 mL LB broth with 50 mg/mL kanamycin. From overnight cultures, 10 mL 
were inoculated into 1 L day cultures and grown approximately 5 hours to mid-log phase. 
Cultures were induced with 1 mM IPTG overnight at 16°C with shaking. Cells were pelleted 
by centrifugation at 8,000 x g for 10 minutes at 4°C. Pellets were resuspended in 10 mL lysis 
buffer (50 mM NaH2PO4, 10 mM tris, 10 mM imidazole) and frozen at -80°C for at least 30 
minutes to initiate cell lysis. Cells were thawed in cold water following addition of 20 mL 
lysis buffer and the protease inhibitor phenylmethanesulfonyl fluoride (PMSF) at a final 
concentration of 1 mM. Lysis was completed by two rounds of sonication for 60 seconds 
each using a microtip with a duty cycle of 40% and output control of 4. Debris was pelleted 
at 10,000 x g for 20 minutes at 4°C and lysates were incubated with 2 mL washed cobalt 
resin with end-over-end rotation for 1 hour at room temperature. The resin-lysate mixture 
was loaded onto a column and the resin bed was allowed to settle. Unbound fraction was 
23 
 
collected and the resin bed was washed by addition of 10 mL wash buffer (50 mM NaH2PO4, 
300 mM NaCl, 10 mM imidazole). This wash was collected for downstream analysis. 
Proteins were then eluted in three fractions of 5 mL total elution buffer (50 mM NaH2PO4, 10 
mM tris, 500 mM imidazole). All fractions were analyzed by SDS-PAGE. Protein was frozen 
at -20°C in 15% glycerol prior to use in thermal shift assays.  
Thermal shift assays 
 Thermal shift assays (TSA) were used to determine the binding capacity of purified 
NspS binding pocket mutant proteins or wild type NspS protein to norspermidine or 
spermidine as described previously [85]. This technique works on the premise that a protein 
is more thermally stable when bound to its ligand. Purified wild-type NspS or NspSE173A, 
NspSD170A, or NspSW261A were dialyzed in TSA buffer (150 mM NaCl, 100 mM HEPES, pH 
7.5) in a 3 mL Slide-a-lyzer® dialysis cassette (Thermo Scientific, Rockford, IL) once for 
three hours at 4°C followed by a second round of dialysis overnight at 4°C. When necessary, 
purified protein was concentrated using a Pierce PES 3K MWCO protein concentrator to 
obtain the appropriate concentration of protein. Reaction mixtures were prepared in a 
Microamp optical 96-well reaction plate (Thermo Scientific, Rockford, IL) with a final 
protein concentration of 4.75 mg/mL (8 μM), spermidine or norspermidine at 1 µM, 10 µM, 
or 100 µM, and SYPRO® Orange fluorescent dye (Invitrogen) at a 5x concentration. A 
baseline for thermal stability of protein only was established by combining purified protein, 
SYPRO® Orange, and TSA buffer. Negative controls containing 100 µM norspermidine and 
SYPRO® Orange were prepared to eliminate the possibility that an interaction was occurring 
between the polyamines and SYPRO® Orange dye. Additional negative controls included 
wild-type NspS, 100 µM cadaverine or putrescine, and SYPRO® Orange to show that the 
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shifts in thermal stability were specific to norspermidine and spermidine. Protein melting 
curves were generated by measuring fluorescence intensity of the reaction mixtures in an 
Applied Biosystems 7500 Real Time PCR System (Grand Island, NY). Melting temperatures 
(Tm) for each protein under various conditions were determined by plotting the first 
derivative of the fluorescent intensity against temperature using Sigma Plot and graphs were 
generated using Microsoft Excel 2010. 
Bioinformatics 
 As membrane-bound proteins are prone to aggregation in aqueous solution, a novel 
approach for showing the NspS-MbaA protein interaction was developed. MbaA contains a 
large periplasmic region proposed to mediate signal transduction from the periplasm to the 
cytoplasm to modulate MbaA PDE activity. In order to show that MbaA interacts with NspS 
in the periplasm, several bioinformatics programs were used to identify the signal sequence 
of NspS (NspSss) required for periplasmic localization of the protein, and the region of MbaA 
localized to the periplasm (MbaAperi). Using this information, a fusion of NspSss to MbaAperi 
could theoretically be generated via splicing by overlap extension. NspSss was identified by 
entering the known amino acid sequence into the signal peptide prediction programs SignalP 
4.1 (http://www.cbs.dtu.dk/services/SignalP/), PrediSi (http://www.predisi.de/), and Phobius 
(http://phobius.sbc.su.se/). These programs agreed that the signal sequence likely comprised 
the first 33 amino acid residues (nucleotides 1-99) of NspS. mbaAperi was identified using 
several protein topology prediction programs including the TMHMM server 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) and TMPred 
(http://www.ch.embnet.org/software/TMPRED_form.html) which identify putative 
transmembrane helices and provide orientation, and TOPCONS (http://topcons.cbr.su.se/) for 
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membrane protein topology predictions based on comparison of target protein amino acid 
sequences to that of solved protein structures. Altogether, these programs suggested the 
periplasmic region to range from amino acid 28-259 (nucleotides 82-777).  
Generation of pFLMP 
 As determined by the bioinformatics programs described above, the NspSss is 
encoded by the first 99 base pairs of the NspS gene. In order to express the NspSss-MbaAperi 
(referred to hereafter as MbaAp) fusion product, a nspSss-mbaAperi construct was generated 
and cloned into the pFLAG-CTC expression plasmid (Sigma-Aldrich, St. Louis, MO) at NdeI 
and SalI restriction sites. A primer encoding the entire 99 base pair nspSss was generated with 
a 5’ NdeI site as well as several guanine and cytosine nucleotides 5’ to this restriction site to 
bring the GC content closer to 50%. As the NdeI sites encodes an in-frame AUG translational 
start site, the native NspS start site was avoided during NspSss construction (referred to 
hereafter as PA253). Additionally, work by Auclair et al. suggested that, because the +1 and 
+2 amino acids following signal peptides of proteins encoded by Gram-negative bacteria are 
highly conserved these amino acids are likely involved in signal peptidase I binding and 
cleavage [86]. Therefore, the next six nucleotides following the predicted nspSss nucleotide 
sequence were added to PA253.  
 The primer pair PA255/256 were designed to amplify the region of mbaA 
corresponding to the nucleotides encoding the predicted periplasmic region (base pairs 28-
720). PA255 also contains the last 23 base pairs of nspSss to facilitate splicing by overlap 
extension, and PA256 adds a 3’ SalI site to facilitate cloning into pFLAG-CTC. The PCR 
settings used included an initial denaturation for 30 seconds at 98°C, followed by 35 cycles 
of denaturation at 98°C for 10 seconds, primer annealing at 54°C for 20 seconds, and 
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extension at 72°C for 30 seconds, and concluded with a final extension step at 72°C for 10 
minutes. The 692 base pair fragment was gel purified and was used in a splicing by overlap 
extension reaction to PA253. Following splicing, the full length nspSss-mbaAperi (referred to 
hereafter as mbaAp) fragment was reamplified using a forward primer, PA254, designed to 
amplify from the beginning of mbaAp, and the reverse mbaAp primer, PA256. The 802 base 
pair amplicon was verified via gel electrophoresis and PCR purified. mbaAp was adenylated 
and TOPO-cloned as according to the manufacturer’s instructions, and the recombinant 
molecule was transformed into DH5α. The plasmid was isolated from transformants, 
sequenced for verification of proper sequence, and digested with NdeI and SalI to release 
mbaAp. The insert was gel purified and ligated into the pFLAG-CTC  expression vector 
linearized with the same restriction endonucleases, and the recombinant molecule, named 
pFLMP, was transformed into DH5α. PCR and restriction digests with NdeI and SalI were 
used to confirm the correct insert was present following plasmid isolation.  
Expression and detection of recombinant MbaAp-FLAG protein 
Expression  
 pFLMP was electroporated into a V. cholerae ΔnspSΔmbaA double mutant strain 
harboring a recombinant wild-type copy of nspS in the form of pACYC184::nspS, as 
described above, to generate AK416. To induce expression of mbaAp, overnight cultures 
were diluted to an OD595=0.04 in fresh media and grown to mid-log phase. Cultures were 
diluted 1:2 in fresh media and induced with 1 mM IPTG overnight at 37°C and cells were 
harvested by centrifugation for 5 minutes at 16,100 x g at room temperature. To confirm 
periplasmic expression of MbaAp, a periplasmic fractionation was performed via osmotic 
shock. Cells were resuspended in Buffer 1 (10 mM tris, 1 mM EDTA, 20% (w/v) sucrose, 4 
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mg/mL lysozyme) and incubated on ice for 5 minutes. The periplasm was released by 
addition of an equal volume of ice cold water. Cell debris was pelleted by centrifugation and 
the supernatant containing the periplasmic fraction was stored at -20°C for subsequent 
analysis by Western blotting. 
Western blotting 
 Samples were combined with equal parts 2X Laemmli buffer and incubated in boiling 
water for 5 minutes prior to SDS-PAGE. Protein was transferred to a PVDF membrane in a 
Mini Trans-Blot® transfer apparatus (BioRad, Hercules, CA). Blots were incubated in 5% 
blocking buffer (PBS, 5% (w/v) skim milk) overnight at 4°C on a rotary shaker. The blot was 
probed with a monoclonal mouse anti-FLAG® M2- antibody conjugated to horse radish 
peroxidase (HRP) in 0.05% PBST for 1 hour with end-over-end rotation at room 
temperature. Blots were washed once for 15 minutes and twice for 5 minutes in 0.05% PBST 
on a rotary shaker. Chemiluminescent detection was performed by incubation for 5 minutes 
with Pierce
TM
 ECL western blotting substrate in the dark. Blots were imaged using a 
Universal Hood III system for Chemidoc MP detection system (Biorad, Hercules, CA).  
In vitro crosslinking by bis(sulfosuccinimidyl) suberate (BS
3
) 
 To investigate the NspS-MbaA interaction, it was necessary to generate the 
appropriate negative controls. To this end, V. cholerae ΔnspSΔmbaA double mutants 
harboring pACYC184::nspS-V5 or an empty pACYC184 vector were transformed with 
pFLAG-CTC and pFLMP, respectively. Cultures were grown and induced as described 
above. Cells were harvested by centrifugation and pellets were washed three times in PBS to 
remove amine-containing media. Cells were resuspended in PBS and the membrane 
impermeable BS
3
 crosslinker was added at a final concentration of 0.5, 1, 2, 3, and 4 mM. 
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BS3 is able to go through the outer membrane porins and localize to the periplasm; however, 
it cannot cross the cytoplasmic membrane. The crosslinking reaction was incubated at room 
temperature for 1 hour at room temperature on an end-over-end rotator prior to quenching 
with 20 mM Tris for 15 minutes. Cells were sonicated on ice three times for 15 seconds and 
cell debris was removed by centrifugation. Supernatants were stored at -20°C for further 
analysis. 
Co-Immunoprecipitation 
Following crosslinking experiments, cells were pelleted and periplasmic fractions were 
released as described above. Periplasmic fractions were incubated with Anti-FLAG M2 
affinity beads or Anti-V5 affinity beads with end-over-end rotation at room temperature for 1 
hour. The supernatant was removed and saved and beads were washed twice in PBS. Beads 
were resuspended in equal volumes of PBS and Laemmli buffer and samples were boiled for 
5 minutes prior to SDS-PAGE. Protein was transferred to a PVDF membrane using a Mini 
Trans-Blot® transfer apparatus. Blots were blocked overnight in 5% (w/v) dried skim milk in 
PBS at 4°C. For blots whose samples were pulled down using anti-FLAG M2 affinity beads, 
an Anti-V5 antibody-HRP conjugate was incubated at a 1:10,000 dilution in PBS for 1 hour 
prior to chemiluminescent detection with the Pierce
TM
 ECL western blotting substrate in the 
dark for 5 minutes. Conversely, for blots whose samples were pulled down using the Anti-V5 
affinity beads, an Anti-FLAG antibody-HRP conjugate was incubated at a 1:10,000 dilution 
in PBS for 1 hour prior to chemiluminescent detection. A Universal Hood III system for 
Chemidoc MP was used to capture images of exposed blots (Biorad, Hercules, CA).  
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c-di-GMP quantification 
 Overnight cultures were diluted 1:50 in 5 mL day cultures containing LB alone, or the 
same supplemented with 100 μM norspermidine or 1 mM spermidine and grown to mid-log 
phase at 37°C with shaking. Three mL of culture were pelleted and cells were resuspended in 
100 μL ice cold extraction buffer (40% methanol, 40% acetonitrile, 1 N formic acid). Tubes 
containing resuspended cells were sealed with parafilm and incubated at 65°C for ten 
minutes to ensure complete lysis. Cells were then incubated at -20°C for 30 minutes and 
solutions were neutralized by adding NH4HCO3 to a final concentration of 0.58% (w/v). Cell 
debris was removed by centrifugation for 5 minutes at 16,100 x g and supernatants were 
transferred to O-ring tubes for storage at -80°C prior to shipping on dry ice for LC-MS/MS 
analysis.  LC-MS/MS analysis was performed by Eric Burger in Dr. Chris Waters’ lab at 
Michigan State University using a Quattro Premier XE mass spectrometer (Waters) coupled 
with a Acquity Ultra Performance LC system (Waters) was used for c-di-GMP detection as 
described previously [46]. 
Expression and purification of NspS for polyclonal antibody production 
 To generate the NspS antibody, approximately 2 mg/mL purified NspS was needed at 
three 1-month intervals for injection in rabbits. Previous work with the system used in our lab 
to overexpress NspS revealed that the majority of protein aggregated in inclusion bodies; 
however, previous work has shown that inclusion bodies may be used for antibody 
production [87].  Therefore, this approach was chosen for producing enough protein antigen 
to be used for antibody generation. 
In order to overexpress NspS, isolated colonies of SHuffle T7 Express E. coli cells 
harboring pET28b::nspS were grown overnight in LB broth at 37°C with shaking. Overnight 
cultures were diluted 1:1000 in 1L of LB and grown to mid-log phase under the same 
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conditions. Once at mid-log phase, cultures were induced overnight with 500 μM IPTG at 
30°C with shaking. Cells were then harvested at 8000 x g for 20 minutes at 4°C. Cells were 
then resuspended in 20 mL denaturing lysis buffer (50 mM NaH2PO4, 10 mM tris, 8 M urea, 
10 mM imidazole) and frozen at -80°C for 30 minutes. Cell lysis was initiated by thawing at 
room temperature with the addition of 60 mL denaturing lysis buffer for 30 minutes followed 
by three rounds of sonication on ice for 60 seconds each using a microtip with a duty cycle of 
40% and output control of 4. Cell debris was pelleted by centrifugation at 14000 x g for 20 
minutes at room temperature and the supernatant was added to 1 mL prepared HisPur
TM
 
cobalt Resin (Thermo Scientific, Rockford, IL). Cobalt resin was prepared by spinning gently 
at 700 x g for two minutes and washing twice in 10 mL denaturing lysis buffer. The cell 
lysate was incubated with cobalt resin overnight at room temperature with end-over-end 
rotation. 
Following incubation, the resin was pelleted at room temperature for five minutes at 
700 x g, resuspended in 10 mL wash buffer (50 mM NaH2PO4, 300 mM NaCl, 8 M urea, 10 
mM imidazole), loaded on a column, and allowed to settle. Once the resin bed had collected 
at the bottom of the column, the wash was eluted and retained. A second wash with 10 mL 
lysis buffer was applied without disturbing the resin. The unbound fraction and combined 
washes were retained for further analysis. Bound protein was eluted with 5 mL elution buffer 
(50 mM NaH2PO4, 10 mM tris, 8 M urea, 500 mM imidazole) in five 1 mL fractions. All 
fractions were analyzed by SDS-PAGE prior to further processing. Inclusion bodies were 
precipitated by dialysis in a Slide-a-lyzer® dialysis cassette (Thermo Scientific, Rockford, 
IL) at 4°C for 6 hours in PBS. Inclusions were pelletted and washed twice in inclusion body 
wash buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 1 M urea, pH 
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7.4) and once in PBS prior to resuspension in PBS and storage at -20°C for antibody 
production. A male New Zealand white rabbit was immunized over an eleven week course at 
weeks 0, 3, 6, 9, and 11 with an emulsion of 0.5 ml of 2 mg/mL antigen in PBS and 0.5 mL 
of Freund’s Complete Adjuvant (Sigma). The rabbit was sacrificed at week 12 and whole 
serum was separated from blood cells by allowing the latter to clot overnight. Whole serum 
was aliquoted and stored at -20°C prior to purification. 
Testing of polyclonal Anti-NspS antibodies via Western blot and ELISA 
Purification of Anti-NspS antibody 
 Whole rabbit serum was purified using a Melon
TM
 Gel IgG spin purification kit from 
Thermo Fisher Scientific (Carlsbad, CA) according to the manufacturer’s instructions. 
Purified antibody was aliquoted and stored at -20°C for later use. Purified antibody was 
compared to whole serum via SDS-PAGE and Coomassie staining analysis. 
Western blotting with the Anti-NspS antibody 
 Overnight cultures were pelleted and resuspended in PBS with 20 µL/mL protease 
inhibitors (Sigma-Aldrich, St. Louis, MO). Cells were sonicated on ice three times and debris 
was pelleted by centrifugation at 16,100 x g for 20 minutes at 4°C. Lysates were run via 
SDS-PAGE and protein was transferred to PVDF membrane in a Mini Trans-Blot® transfer 
apparatus. Following transfer, blots were blocked overnight in 5% (w/v) skim milk in PBS at 
4°C. Blots were incubated with purified anti-NspS antibody at a final concentration of 1 
μg/mL in 3% (w/v) skim milk in 0.05% PBST for 1 hour at room temperature, washed three 
times in 0.05% PBST for 5 minutes each, and incubated with goat anti-rabbit-HRP antibody 
conjugate at a 1:10,000 dilution in PBST for 1 hour with end-over-end rotation at room 
temperature. Blots were washed once for 15 minutes in 0.05% PBST followed by two more 
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washes in the same for 5 minutes each. Chemiluminescent detection was performed as 
described above. 
 
NspS ELISA  
 To test the anti-NspS antibody efficacy in ELISA experiments, high affinity 
microtiter plates were coated with anti-NspS capture antibody at 1 μg/mL in carbonate buffer 
pH 9.6 overnight at 4°C. On the next day, coating solution was removed and the plate was 
washed twice with PBS, and plates were blocked with 5% (w/v) dried skim milk in 0.05% 
PBST for 2 hours at room temperature. Periplasmic extracts or whole cell lysates, prepared 
by sonication or using Bugbuster® Protein Extraction Reagent (Thermo Scientific, Waltham, 
MA), from AK192 or AK007 were added to wells in sequential 1:2 dilutions and incubated 2 
hours at room temperature for capture. Wells were washed four times with PBS and Anti-V5 
antibody-HRP conjugate was added at a 1:1000 dilution in PBST for 1 hour. The plate was 
washed four times with PBST and incubated with 3, 3’, 5, 5’-tetramethylbensidine (TMB) 
substrate for 10 minutes in the dark. Reactions were stopped by adding an equal volume of 
phosphoric acid prior to measuring the OD450.  
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Results 
 
 
Mutations in the NspS binding cleft alter polyamine-mediated influences on biofilm 
formation 
 NspS has been shown to have a positive influence on biofilm formation (Karatan et 
al. 2005), and mutation of specific binding pocket residues hypothesized to be involved in 
mediating polyamine binding has severe impacts on biofilm formation in vitro [82]. 
Additionally, the polyamines norspermidine and spermidine have been shown to increase and 
decrease biofilm formation of wild type V. cholerae, respectively, in a nspS-dependent 
manner. Therefore, it was hypothesized that addition of these polyamines would have less, if 
any, influence on polyamine-mediated biofilm formation by strains producing NspS binding 
pocket mutants. Three strains expressing nspS with putative ligand-binding residue mutations 
to alanine were chosen for further analysis; these residues include Glu173, Asp170, and 
Trp261. 
To test the impact of binding cleft mutations on NspS-mediated signaling in response 
to norspermidine, mid-log phase cultures were diluted to an OD595 of 0.04 in fresh tryptone 
or LB media only, or in the presence of increasing concentrations of norspermidine (10 µM, 
100 µM, or 1 mM). As LB contains variable levels of spermidine (approximately 10-40 μM), 
these experiments were performed in both, LB and tryptone media to determine what 
differences may be observed for biofilm formation in these media types. Cultures were 
grown statically for 48 hours at which point biofilms were dispersed with glass beads and 
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vortexing, and biofilm cell density was measured (Figure 5). Addition of norspermidine to 
culture medium had a statistically significant positive influence on strains harboring wild-
type NspS when grown in both tryptone broth (Figure 5A) and LB media (Figure 5B), while 
the ΔnspS mutant formed little to no biofilms under these conditions regardless of the growth 
medium. Interestingly, the nspSE173A mutant formed robust biofilms comparable to wild-type 
in tryptone media, or greater than wild type in LB, but did not respond to norspermidine 
addition. In contrast, nspSD170A and nspSW261A formed very low biofilms in media alone. At 
both 100 µM and 1 mM norspermidine, both strains formed very robust biofilms comparable 
to both wild-type and the nspSE173A mutant. However, nspSW261A did not respond to the lower 
concentration of 10 µM norspermidine, while nspSD170A doubled its biofilm mass at this 
concentration. Notably, strains expressing wild-type nspS, nspSD170A, or nspSW261A all show a 
slight decrease in biofilm formation at 1 mM norspermidine as compared to 100 µM 
norspermidine when grown in tryptone broth.  Another perhaps less surprising observation is 
that all strains grew much more slowly in tryptone broth (OD595=0.2 for untreated wild-type 
cultures) as compared to the more complex LB medium (OD595=0.3 for untreated wild-type 
cultures), regardless of polyamine addition (Figure 6A and B). In comparing LB, the ratios of 
planktonic to biofilm cells appear to compensate one another i.e. as cells partition into the 
biofilm fraction, planktonic cell density decreases noticeably. In contrast, partitioning of cells 
from the planktonic fraction is less noticeable for cultures grown in tryptone. This may be 
due to the decreased growth rate of these cultures as compared to those grown in LB. 
Altogether, these data indicate that the varying polyamine conditions used in these assays did 
not appear to impart a growth defect for any given strain.  
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Figure 5: Biofilm formation in media alone or with increasing concentrations of 
norspermidine. Biofilm formation was compared for ∆nspS mutants with pACYC184 vector 
only, or complemented with nspSE173A, nspSD170A, nspSW261A, or wild-type (WT) nspS. Mid-
log cells were diluted to an OD595 of 0.04 in fresh tryptone (A) or LB (B) alone (white bars) 
or supplemented with various concentrations of norspermidine. Norspermidine 
concentrations include 10 µM (light grey bars), 100 µM (dark grey bars), and 1 mM (black 
bars). Following 48 hours of static incubation at 27°C, planktonic cells were removed and 
biofilms were sheared with glass beads and vortexing. Biofilm cell density was measured at 
OD595. Single stars indicate significant differences compared to wild-type cultures grown in 
the absence of norspermidine (p<0.05). Double stars indicate significant differences of 
biofilm formation for the specific strain and treatment as compared to the same strain without 
norspermidine addition. Error bars show standard deviation of three biological replicates 
(p<0.05). Statistical analysis was performed using two-way ANOVA in Sigma Plot. 
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Figure 6: Planktonic growth in media alone or with increasing concentrations of 
norspermidine. Planktonic cell growth was compared for ∆nspS mutants with pACYC184 
vector only, or complemented with nspSE173A, nspSD170A, nspSW261A, or wild-type (WT) nspS. 
Mid-log cells were diluted to an OD595 of 0.04 in fresh tryptone (A) or LB (B) alone (white 
bars) or supplemented with various concentrations of spermidine. Norspermidine 
concentrations include 10 µM (light grey bars), 100 µM (dark grey bars), and 1 mM (black 
bars). Following 48 hours of static incubation at 27°C, planktonic cells were removed and 
measured at an OD595. Error bars show standard deviation of three biological replicates 
(p<0.05).  
 
0
0.05
0.1
0.15
0.2
0.25
Vector only E173A D170A W261A WT
O
D
5
9
5 
Strain 
A 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
Vector only E173A D170A W261A WT
O
D
5
9
5
 
Strain 
B 
37 
 
 The impact of NspS binding pocket mutants on biofilm responsiveness to spermidine 
addition was also tested for cultures grown in tryptone or LB media using the same 
concentrations described for norspermidine (Figure 7). Again, ΔnspS mutants harboring a 
wild-type nspS complement formed increased biofilms when grown in media alone as 
compared to the vector-only control which was unresponsive at all concentrations of 
spermidine. As seen previously, spermidine addition did not significantly influence wild-type 
strains until concentrations reached 1 mM at which point a decrease of about 25% in biofilm 
formation was observed in either medium. In contrast, and similar to observations made with 
norspermidine, the nspSE173A mutant was unresponsive to spermidine addition at all 
concentrations when grown in LB media. However, when grown in tryptone, the same 
mutant responded with a significant increase in biofilm formation in the presence of 100 µM 
spermidine, but biofilm formation was repressed back to levels seen in the absence of this 
polyamine when grown in the presence of 1000 µM spermidine. This observation suggests 
that other players may be contributing additively biofilm formation in response to this 
polyamine. Contrary to observations with norspermidine, nspSW261A did not respond to any 
concentration of spermidine and maintained a relatively low biofilm cell density under all 
conditions. Notably, nspSD170A showed a slight yet significant decrease in biofilm formation 
in the presence of 1 mM spermidine in both tryptone and LB. Again, all strains grew much 
more rapidly in LB medium than tryptone broth regardless of polyamine addition (Figure 8A 
and B, respectively) and increased partitioning to biofilms in LB resulted in a noticeable 
compensatory decrease in planktonic cell density such that strains which grew increased 
biofilms had yielded fewer numbers in the planktonic fraction. Altogether, biofilm 
observations show that the conserved binding pocket residue E173 may be important for  
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norspermidine and spermidine-mediated control of biofilms while D170 and W261 may be 
necessary for signaling by spermidine alone. 
 
 
 
 
Figure 7: Biofilm formation in media alone or with increasing concentrations of 
spermidine. Biofilm formation was compared for ∆nspS mutants with pACYC184 vector 
only, or complemented with nspSE173A, nspSD170A, nspSW261A, or wild-type (WT) nspS. Mid-
log cells were diluted to an OD595 of 0.04 in fresh tryptone (A) or LB (B) alone (white bars) 
or supplemented with various concentrations of spermidine. Spermidine concentrations 
include 10 µM (light grey bars), 100 µM (dark grey bars), and 1 mM (black bars). Following 
48 hours of static incubation at 27°C, planktonic cells were removed and biofilms were 
sheared with glass beads and vortexing. Biofilm cell density was measured at OD595. Single 
stars indicate significant differences compared to wild-type cultures grown in the absence of 
spermidine Double stars indicate significant differences of biofilm formation for the specific 
strain and treatment as compared to the same strain without spermidine addition. Error bars 
show standard deviation of three biological replicates (p<0.05). Statistical analysis was 
performed using two-way ANOVA in Sigma Plot. 
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Figure 8: Planktonic growth in media alone or with increasing concentrations of 
spermidine. Planktonic cell growth was compared for ∆nspS mutants with pACYC184 
vector only, or complemented with nspSE173A, nspSD170A, nspSW261A, or wild-type (WT) nspS. 
Mid-log cells were diluted to an OD595 of 0.04 in fresh tryptone (A) or LB (B) alone (white 
bars) or supplemented with various concentrations of spermidine. Spermidine concentrations 
include 10 µM (light grey bars), 100 µM (dark grey bars), and 1 mM (black bars). Following 
48 hours of static incubation at 27°C, planktonic cells were removed and measured at an 
OD595. Error bars show standard deviation of three biological replicates (p<0.05).  
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NspS ligand-binding pocket mutants have altered colony morphologies 
I hypothesized that the increased biofilm phenotype noted for nspS mutants grown in 
LB static cultures may be the results of increased VPS production which has been shown 
previously to result in corrugated or rugose colony morphology. However, it was noted that 
even in the absence of polyamines colony morphology of nspS binding-binding pocket 
mutants on LB media differed noticeably from that of wild-type V. cholerae (Figure 9). 
While ΔnspS mutant strains containing vector only, nspSD170A, or nspSW261A produced 
comparatively smooth colonies, the nspSE173A mutant formed wrinkly colonies indicative of 
increased polysaccharide content as compared to the intermediate rugose appearance of that 
expressing wild-type nspS. 
 
 
Figure 9: Colony morphologies of nspS ligand-binding pocket mutants. V. cholerae 
ΔnspS mutants harboring a pACYC184 vector alone, or with wild-type nspS or nspS ligand-
binding pocket mutants were grown on LB agar with 2.5 µg/mL tetracycline for 24 hours 
prior to imaging through an Olympus SZ12 stereoscope at 25.6 x magnification. From left to 
right, nspS mutants were complemented with: vector only, nspSE173A, nspSD170A, nspSW261A, 
and wild-type nspS. 
 
Mutations in the NspS ligand-binding cleft alter polyamine-mediated influences on vps 
transcription 
 
 V. cholerae biofilm matrix is largely composed of polysaccharide, extracellular DNA, 
and protein. The production and export of the polysaccharide component is dependent upon 
transcription of Vibrio polysaccharide (VPS) genes located within two clusters (vpsI and 
vpsII) on the large chromosome consisting of vpsA-K and vpsL-Q. Previous research in our 
lab has shown that vpsL promoter activity is increased in wild-type strains grown in the 
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presence of as little as 10-30 µM norspermidine, and that these effects are abolished in a 
ΔnspS mutant. Therefore, to investigate whether the biofilm phenotypes observed for nspS 
ligand-binding pocket mutants were a direct result of altered vps gene transcription, β-
galactosidase assays were performed making use of a chromosomal vpsLp-lacZ fusion in the 
ΔnspS background (Figure 10). Using this construct, one can correlate β-galactosidase 
activity to vpsL promoter activity by adding a colorimetric substrate, o-nitrophenyl-β-
galactoside (ONPG), to cell lysates. Production of the derivative product of ONPG, o-
nitrophenol, results in a yellow color change which can be quantified at an OD415. To this 
end, overnight cultures were diluted to an OD595 of 0.04 in fresh tryptone media only, or in 
the presence of 100 µM norspermidine or 1 mM spermidine and grown statically to mid-log 
phase. The OD595 of planktonic cells was recorded for standardization and pelleted. Cells 
were washed once in Z-buffer, pellets were frozen to initiate lysis, and cells were 
resuspended in the same to complete lysis by sonication. Cell debris was pelleted and ONPG 
was added to lysates until a color change was observed. 
 As seen in Figure 11, a slight increase in vpsLp activity was observed for strains 
harboring wild-type nspS when grown in the presence of norspermidine; however, this 
difference was not statistically significant under the conditions tested. In contrast, a 
statistically significant decrease was observed for the same in spermidine-containing media. 
Very low vpsLp activity was observed for the ΔnspS mutant under all conditions. As expected 
based on observations made for biofilms by this strain, the nspSE173A mutant showed high 
transcription from vpsLp in tryptone alone and was unresponsive to both, norspermidine and 
spermidine. Additionally, nspSW261A showed initially low vpsLp transcription, but a  
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Figure 10: Diagram of the chromosomal vpsLp-lacZ fusion used for vps assays. 
 
 
 
Figure 11: vpsL transcription in media alone or in the presence of 100 μM 
norspermidine (nspd) or 1 mM spermidine (spd). Vps transcription was compared for 
∆nspS mutants with pACYC184 vector only, or complemented with nspSE173A, nspSD170A, 
nspSW261A, or wild-type (WT) nspS. Overnight cultures were diluted to OD595 of 0.04 in fresh 
tryptone media only (white bars), or media containing 100 µM norspermidine (grey bars) or 
1 mM spermidine (black bars) and grown to mid-log phase. Cells were harvested for washing 
and lysed by sonication prior to incubation of the lysate with ONPG. Miller units of β-
galactosidase activity were calculated as described in Materials and Methods. Single stars 
indicate significant differences compared to wild-type cultures grown in the absence of 
spermidine (p<0.05). Double stars indicate significant differences of Miller units for the 
specific strain and treatment as compared to the same strain without polyamine addition. 
Error bars show standard deviation of three biological replicates (p<0.05). Statistical analysis 
was performed using two-way ANOVA in Sigma Plot. 
 
significant positive vpsLp transcriptional response to norspermidine while spermidine had no 
apparent effect. Further corroborating biofilm observations, vpsL promoter activity was low 
for nspSD170A in tryptone alone, but responded with over a two-fold increase to 
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in the presence or absence of norspermidine and spermidine are a direct result of altered vps 
gene transcription imparted by these mutants. 
Global c-di-GMP pools are unaffected by norspermidine and spermidine or presence of 
NspS and MbaA 
 MbaA is confirmed to have PDE activity in vitro which is unchecked in the absence 
of NspS leading to degradation of c-di-GMP, and reduction of vps transcription and biofilm 
formation [81]. To determine if cellular c-di-GMP pools are affected by signal transduction 
mediated by NspS in the presence or absence of norspermidine or spermidine, wild-type V. 
cholerae or a ∆nspS mutant were grown to mid-log phase in media only or in the presence of 
100 μM norspermidine or 1 mM spermidine. c-di-GMP was extracted and quantified as 
described previously [46]. As shown in Figure 12, c-di-GMP levels are maintained at 
approximately 45-65 nM regardless of polyamine concentration, or presence of NspS 
indicative of a high specificity signaling system.  
 
Figure 12: Cellular c-di-GMP levels of ∆nspS mutants in the presence and absence of 
norspermidine (nspd) or spermidine (spd) compared to wild-type (WT). Overnight 
cultures were diluted 1:50 in fresh media with alone or supplemented with 100 μM nspd or 1 
mM spd and grown to mid-log phase. c-di-GMP was extracted as described in Materials and 
Methods and quantified by LC-MS/MS. Error bars show standard deviation of three 
biological replicates (p<0.05).  
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Purification of wild-type NspS and ligand-binding pocket mutants 
The current working model for norspermidine- and spermidine-mediated signaling 
through NspS requires that NspS directly interacts with either polyamine within the 
periplasm causing a conformational change in NspS which induces or alters an interaction 
between NspS and MbaA. This signal is then transmitted to the cytoplasmic domains of the 
latter to influence PDE activity, alter some pool of c-di-GMP, and influence vps 
transcriptional activity to control biofilm formation. Therefore, it was hypothesized that 
alterations at proposed NspS ligand-binding pocket residues would in turn hinder the ability 
of NspS to bind norspermidine and/or spermidine. Previously, it was shown using thermal 
shift assays (TSA) that purified wild-type NspS is capable of binding norspermidine and 
spermidine, but not other polyamines, specifically putrescine and cadaverine [81].  
In an effort to determine the affinity of the binding pocket mutants to norspermidine and 
spermidine, the wild-type or the altered NspS proteins were purified using an E. coli-based 
expression system. Wild-type or mutant nspS genes, each lacking the periplasmic signal 
sequence, were expressed from a pET28b plasmid under the control of the IPTG-inducible 
lac promoter. Additionally, the pET28b plasmid adds a 6-Histidine (6-His) tag which has a 
high affinity for Co
2+
 permitting protein purification. Previous work in our lab has shown 
that optimal soluble nspS expression may be achieved by overnight induction of mid-log 
phase cultures with 1 mM IPTG. A second screen was used to determine that increased 
soluble protein recovery could be achieved by inducing overnight at 16°C as opposed to 
30°C. Cells were harvested by centrifugation and lysed by one freeze-thaw cycle followed by 
sonication. The 40 kDa NspS protein was purified using a Co
2+
 resin and analyzed by SDS-
PAGE and Coomassie staining (Figure 13). Panel A shows the wild-type NspS fractions 
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(lanes 2-7) including whole cell lysate (WCL), unbound fraction (UBF), wash (W), and 
elutions (E1-3). NspSD170A fractions are present on Panel A (lane 8-10) and Panel B (lane 1-
3). NspSW261A fractions are shown in Panel B (lane 5-10) and NspSE173A samples are shown 
in Panel C. As shown in Figure 13, all elutions contained large amounts of purified wild-type 
or mutant protein. 
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Figure 13: Purification of recombinant NspS proteins. Mid-log cultures were induced 
overnight at 16°C with 1 mM IPTG. Cells were harvested, lysed, and the supernatants were 
bound to Co
2+
 resin at room temperature for 1 hour. The resin was washed and bound protein 
was eluted in three fractions. Protein samples were run via SDS-PAGE on three gels as 
follows: Panel A Lane 2-7 wild-type NspS, Panel A Lane 8-10 and Panel B Lane 1-3 
NspSD170A, Panel B Lane 5-10 NspSW261A, Panel C Lane 2, 3, 5, 7-9 NspSD173A. Legend: SM 
– size marker, WCL – whole cell lysate, UBF – unbound fraction, W – wash, E – elution, B – 
beads, X – buffer lane. 
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NspS ligand-binding pocket mutants maintain the capacity to bind norspermidine and 
spermidine 
 To compare the thermal stability profile of purified wild-type or mutant NspS protein 
in the presence of increasing concentrations of norspermidine or spermidine to that of protein 
alone, TSAs were performed. These experiments work on the principal that binding proteins 
are more thermally stable when bound to a ligand. Reaction mixtures consist of target 
protein, a fluorescent dye such as SYPRO Orange®, and a putative ligand. SYPRO® Orange 
nonspecifically binds hydrophobic surfaces and residues leading to increased fluorescence 
while aqueous solution quenches said fluorescence. Therefore, as the reaction mixture is 
heated in a stepwise manner, protein begins to unfold and the hydrophobic interior becomes 
exposed resulting in increased SYPRO® Orange binding to the protein and increased 
fluorescence. By plotting the rate of change of fluorescence intensity as a function of 
temperature, the Tm of the protein may be determined where Tm is the temperature at which 
the rate of change of fluorescence intensity is at its maximum. 
It was previously determined using TSAs that purified wild-type NspS interacts 
specifically with norspermidine and spermidine, but not cadaverine or putrescine [81]. To 
further support these observations, a control was performed with NspS protein alone, or in 
the presence of 100 μM norspermidine, cadaverine, or putrescine (Figure 14). Indeed, while 
an 8°C shift in the Tm was observed for NspS in the presence of norspermidine as compared 
to protein only, neither putrescine nor cadaverine influenced NspS stability indicating lack of 
a binding event for these latter polyamines. However, as seen in Figure 15, addition of as 
little as 1 µM norspermidine or spermidine resulted in a 2-3°C shift in thermal stability while 
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10µM and 100 µM norspermidine and spermidine resulted in about 5-6°C and 7-8° shifts for 
the respective concentrations compared to protein alone.  
 
 
Figure 14: Binding of various polyamines to NspS. Purified NspS protein was combined in 
96-well optical plates with SYPRO Orange in reaction buffer only, or increasing 
concentrations of norspermidine. Blue line-NpsS only, red line-100 µM norspermidine, green 
line-100 µM putrescine, purple line-100 µM cadaverine. Tm is the peak of respective curves. 
 
 The nspSE173A mutant produces robust biofilms, expresses vps genes at high levels in 
media only, and is unresponsive to norspermidine and spermidine addition. As such, it was 
hypothesized that purified NspS mutant protein product would be unable to bind these 
polyamines. However, TSAs indicate that in the presence of increasing concentrations of 
norspermidine and spermidine, purified NspSD173A protein increases in thermal stability 
similarly for both polyamines under the conditions tested (Figure 16). Indeed, a 2°C shift in 
thermal stability was observed for this protein in the presence of 1 µM norspermidine or 
spermidine compared to protein alone. Subsequent shifts of 5°C were observed for protein in 
the presence of 10 µM norspermidine or spermidine, and approximately 8-9°C 100 µM 
concentrations. These data suggest that, although nspSE173A mutants do not respond to either 
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polyamine with a biofilm phenotype or vps transcriptional profile under the conditions tested, 
purified protein is capable of binding both polyamines in vitro. 
 
 
 
 
 
 
Figure 15: Binding of wild-type NspS to various concentrations of norspermidine (A) 
and spermidine (B). Blue line-protein only, red line-10 µM polyamine, green line-100 µM 
polyamine, purple line-1 mM polyamine. Tm is the peak of respective curves. 
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formation and vps transcription with addition of intermediate and high levels (100 µM and 1 
mM) of norspermidine. In contrast, the nspSD170A mutant responded to spermidine addition 
similarly to wild-type when grown in LB medium as both of these strains produced lower 
levels of biofilms and vps transcripts only at 1 mM spermidine. The nspSW261A mutant was 
unresponsive to spermidine. It was therefore hypothesized that NspSD170A may be capable of 
binding both polyamines, but perhaps to a lesser extent in the case of norspermidine at lower 
concentrations. Conversely, it was hypothesized that NspSW261A may have a norspermidine-
binding profile similar to NspSD170A, but a decreased capacity to bind spermidine. However, 
TSA experiments for both mutants indicate that each protein is capable of binding 
norspermidine and spermidine at all concentrations tested. In the case of both, NspSD170A and 
NspSW261A, consecutive thermal shifts of 2-3°C, 4-5°C, and 7-8°C are seen for both 
norspermidine (Figure 17A and 18A, respectively) and spermidine (Figure 17B and 18B 
respectively). Interestingly, and similar to wild-type NspS protein, norspermidine tends to 
increase thermal stability by 1-2°C at 1 mM concentrations as compared to spermidine at the 
same concentration. It is interesting to note that NspSW261A protein unfolding in the absence 
of polyamines occurred at much lower temperatures than wild-type NspS or other mutants 
(about 35°C as compared to around 47°C). These observations may indicate that this mutant 
is less stable than wild-type NspS or the other two mutants under the conditions tested. 
Additionally, the NspSW261A mutant produced two peaks under all conditions tested 
indicating that some other variable may be imparting its own effects on the fluorescence 
curve of this mutant. As the initial stability of this protein appears to be significantly reduced 
as compare to that of other NspS proteins, it may be possible that a degradation product of 
the NspSW261A mutant may be forming and that this product maintains the capacity to bind 
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both polyamines. In this scenario, the fluorescence curve of the derivative product may be 
imparting its own influences on the curve of the full length protein resulting in the bimodal 
appearance of these curves under these conditions. 
 
 
 
 
Figure 16: Binding of the E173A mutant to various concentrations of norspermidine (A) 
and spermidine (B). Blue line-protein only, red line-10 µM polyamine, green line-100 µM 
polyamine, purple line-1 mM polyamine. Tm is the peak of respective curves. 
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Figure 17: Binding of the D170A mutant to various concentrations of norspermidine 
(A) and spermidine (B). Blue line-protein only, red line-10 µM polyamine, green line-100 
µM polyamine, purple line-1 mM polyamine. 
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Figure 18: Binding of the W261A mutant to various concentrations of norspermidine 
(left) and spermidine (right). Blue line-protein only, red line-10 µM polyamine, green line-
100 µM polyamine, purple line-1 mM polyamine. 
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The periplasmic region of MbaA may be expressed in the periplasm independently of the 
transmembrane and cytoplasmic regions 
 
Generation of pFLMP 
 Several lines of evidence suggest that NspS and MbaA interact in the periplasm to 
convey extracellular polyamine signals across the inner membrane to the cytoplasm and 
control biofilm formation in response to select polyamines. Evidence for the NspS-MbaA 
interaction has been obtained through co-immunoprecipitation experiments; however, 
reproducibility has been an issue perhaps due to the low expression of nspS and mbaA 
(Brennan WB, Karatan E, unpublished data) in addition to solubility issues with membrane 
proteins. Therefore, I have developed an alternative approach at studying the NspS-MbaA 
interaction. To this end, a construct comprising a fusion of the periplasmic region of MbaA, 
as well as the NspS signal sequence required for periplasmic localization of NspS was 
developed for expression from an inducible expression plasmid, pFLAG. A flowchart 
illustrating the cloning strategy employed to generate pFLMP is shown in Figure 19A. 
Several bioinformatics programs were used to identify the nucleotide sequence encoding the 
periplasmic domain of MbaA. The 693 base pair nucleotide sequence encoding this domain 
was amplified by PCR (Figure 19B), gel purified, and spliced at the 5’ end to the 99 base pair 
nspS signal sequence with six additional 5’ nucleotides encoding two amino acids predicted 
to be involved in signal peptidase recognition and cleavage to induce periplasmic localization 
(Figure 19C). The identity and presence of the mbaAp construct was confirmed by 
sequencing and colony PCR (Figure 19D), respectively. The approximately 800 base pair 
construct was ultimately cloned into the pFLAG-CTC expression vector and transformed into 
a V. cholerae ΔnspSΔmbaA double mutant with nspS complemented on a pACYC184 
plasmid.  
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Figure 19: Production of nspSss-mbaAperi (mbaAp). Flowchart of pFLMP construction (A). 
Gel image of mbaAperi PCR product (B). Fusion product of nspSss-mbaAperi (mbaAp) (C). 
Colony PCR for mbaAp in DH5α candidates with pFLMP (D). 
 
Detection of MbaAp-FLAG and NspS-V5 in the periplasm 
 Following construction of pFLMP, it was necessary to ensure stability of MbaAp and 
confirm periplasmic localization using a Western blot in the presence and absence of NspS. 
pFLMP was transformed into a ∆nspS∆mbaA mutant (PW522) containing the 
pACYC184::nspS-V5 (pNP1) plasmid. Appropriate controls for downstream co-
immunoprecipitations were also generated by transforming the double mutant with 1) pNP1 
and an empty pFLAG vector to generate AK426 and 2) pFLMP and an empty pACYC184 
vector (AK442). Western blots using the anti-FLAG antibody or the anti-V5 antibody were 
performed with periplasmic extracts from these strains (Figure 20). As seen in the Figure 
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20A, MbaAp was detected at 29 kDa in bacteria harboring pFLMP only when grown in the 
presence of IPTG as expected. 
  
 
 
 
Figure 20: Western blots for MbaAp-FLAG and NspS-V5 expression in the periplasm. 
Periplasmic fractions were obtained from ∆nspS∆mbaA double mutants harboring plasmids 
encoding NspS-V5 from a pACYC184 vector and/or MbaA-FLAG from a pFLAG vector. 
For control strains lacking the nspS-V5 or mbaAp constructs, the corresponding empty vector 
was supplied. FLAG antibody (A) and V5 antibody (B). I and U correspond to induced and 
uninduced culture extracts, respectively. 
 
In contrast, NspS was detected at approximately 40 kDa in all bacteria harboring pNP1 
regardless of the growth in the presence (I) or absence (U) of IPTG as predicted for inserts 
constitutively expressed on the pACYC184 plasmid. (Figure 20B). In strains with 
pACYC184 or pFLAG plasmids lacking nspS-V5 or mbaAp inserts, NspS-V5 or MbaAp 
protein was not detected, respectively. Altogether, these data indicate the both NspS-V5 and 
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MbaAp-FLAG are stable and expressed in the periplasmic fractions of strains harboring the 
respective pNP1 and pFLMP plasmids. 
Co-immunoprecipitation of NspS-V5 and MbaAp 
 In an effort to show that NspS interacts with the periplasmic region of MbaA, co-
immunoprecipitations were performed making use of the inner membrane impermeable 
crosslinker, BS
3
. Mid-log phase cultures were washed and incubated with BS
3
 crosslinker 
with agitation. Periplasmic fractions were extracted and incubated with agarose beads bound 
to either anti-V5 or anti-FLAG antibodies. Subsequently washed beads (B), periplasmic 
extracts (E), and unbound fractions (S) of extracts incubated with beads were subjected to 
Western blots using the reciprocal anti-FLAG (Figure 21A) or anti-V5 antibodies (Figure 
21B). As seen in the left panel, MbaAp was detected in periplasmic extracts and anti-FLAG 
affinity bead fraction of both strains in which mbaAp was expressed regardless of the 
presence of nspS-V5 as indicated by 29 kDa bands. This indicates that nonspecific pull-down 
of MbaAp occurred in extracts from strains lacking the nspS-V5 complement, potentially due 
to binding of MbaAp-FLAG to the agarose beads themselves. Similarly, NspS-V5 was 
detected at approximately 40 kDa in all fractions of strains expressing nspS-V5 regardless of 
presence MbaAp indicating nonspecific pull-down by anti-V5 agarose beads. Additionally, a 
wide range of BS
3
 concentrations (0, 0.5, 1, 2, 3, and 4, mM) were used in additional 
experiments to eliminate the possibility of oversaturation with the BS
3
 crosslinker which 
could lead to large oligomers that may be hindered in gel electrophoresis and/or transfer to 
the PVDF membrane (data not shown). However, while these experiments showed 80 kDa 
bands indicating potential dimerization of NspS as previously shown [83], the expected band 
size of 69 kDa comprised of the 29 kDa MbaAp and 40 kDa NspS-V5 proteins was not 
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detected. Heterotetramers consisting of NspS and MbaA have been reported in the 
aforementioned co-immunoprecipitation experiments.  Therefore, it is possible that 
oversaturation of the BS
3
 crosslinker is occurring and that NspS-MbaAp heterotetramers 
comprising a 138 kDa complex remain undetected in co-immunoprecipitation experiments 
due to incomplete transfer. Future experiments to investigate this possibility will include 
performing overnight transfers at 4°C to allow for more complete transfer of larger 
oligomers. Notably, Figure 21A reveals a 58 kDa band in bead samples of strains expressing 
mbaAp indicating potential dimerization of MbaAp. Optimization experiments are currently 
under way to eliminate nonspecific pull-down of target protein in these experiments. Some of 
these optimization approaches include varying the concentration of BS
3
 crosslinker added to 
resuspended cells and the use of detergents during resin binding steps. 
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Figure 21: Co-immunoprecipitations for NspS-V5 and MbaAp. A. shows blots with 
samples pulled down using agarose-anti-V5 beads and subjected to anti-FLAG antibody 
detection while B. shows blots with samples pulled down using agarose-anti-FLAG beads 
and subjected to anti-V5 antibody detection. E-periplasmic extracts, B-corresponding agarose 
beads, S-supernatant from extracts incubated with beads. 
 
Generation and purification of the polyclonal Anti-NspS antibody 
 Once a reproducible co-immunoprecipitation assay is developed for detection of the 
proposed NspS-MbaA interaction, the next step will be to identify a binding interface on 
these proteins. In order to accomplish this, error prone PCR or a mutagenesis kit will be used 
to generate point mutations along the entirety of the nspS sequence and mutants will be 
cloned into a ΔnspS mutant strain of V. cholerae to identify NspS mutants defective in 
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biofilm formation using biofilm assays described above. Using this method, it may be 
necessary to screen several hundred to several thousand mutants to dismiss those mutations 
which cause reduced biofilm formation as a result of decreased protein stability, premature 
stop codons, or mutations at the promoter region. Fast screening approaches such as ELISA 
would significantly reduce time expenditure and effort required for more tedious approaches 
such as Western blotting. ELISAs require two antibodies: one specific to the protein of 
interest to pull down protein from cell extracts, and another specific to a different epitope to 
be used in detection of the protein in the cell extracts. To this end, a polyclonal anti-NspS 
antibody could be used as the capture antibody and a second V5 antibody-HRP conjugate 
which specifically binds the V5 epitope tag fused to the C-terminus of NspS mutants would 
be used to determine protein levels colorimetrically. Following the initial screening 
processes, ELISAs could be used to identify strains harboring mutations which inhibit NspS-
MbaA binding. In such a scenario, the polyclonal anti-NspS antibody would again serve as 
the capture antibody. Periplasmic extracts of ∆nspS∆mbaA strains harboring the pFLMP 
plasmid as well as NspS mutants would then be screened for NspS-MbaAp interaction using 
the anti-FLAG antibody. For NspS mutants that are unable to interact with MbaAp, 
colorimetric change would not be observed and corresponding nspS mutant genes would 
subsequently be sequenced to identify the mutations which prevent interaction. Localization 
of these specific residues could then be determined using homology modeling to map 
residues likely to be present on the NspS surface. Surface residues which prevent the 
interaction would likely play a role in mediating said interaction.  
In preparation for these screens, a polyclonal anti-NspS antibody was generated 
against purified NspS protein in rabbits. Previous research in our lab has shown that the 
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majority of NspS protein produced using the pET28b::nspS construct in E. coli tends to 
aggregate in an insoluble form of protein known as inclusion bodies. Recent research has 
shown, however, that inclusion bodies may be used for antibody generation (Yang et al. 
2011). Therefore, urea-based denaturing conditions were used to solubilize NspS inclusions 
in order to obtain enough NspS antigen for rabbit immunizations and all fractions were 
analyzed via SDS-PAGE and Coomassie staining as seen in the representative image 
displayed in Figure 22. Although a large amount of protein remained in the unbound fraction 
(UBF) and came off in the resin wash (W), a sufficient amount of NspS was recovered in the 
elution fractions (E1-5) under these conditions. Previously purified NspS protein was used as 
a secondary size marker (NspS). 
NspS inclusions were precipitated following purification via dialysis into PBS, and 
washed to remove contaminating protein. These inclusions were used in rabbit 
immunizations over the course of three months prior to sacrifice and harvesting of whole 
rabbit serum. Antibodies were purified from whole serum using an IgG spin purification kit 
and compared to the latter using SDS-PAGE and Coomassie staining (Figure 23). As 
expected for IgG, antibodies purified from whole serum produced a 50 kDa band 
corresponding to the heavy chain and a very faint 25 kDa band corresponding to the light 
chain is also present.  The purification kit contains a gel resin which binds serum proteins 
which comprise the majority of what is visible in the whole serum fraction. Following serum 
protein binding, purified IgG antibody may be collected in the flowthrough. 
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Figure 22: Coomassie-stained SDS-PAGE gel of NspS purified using denaturing 
conditions. Labels are as follows: SM-size marker, UBF-unbound fraction, W-wash, E1-5-
elutions 1-5, B-buffer lane, NspS-purified NspS control. 
 
 
 
Figure 23: SDS-PAGE gel of purified anti-NspS antibody. Anti-NspS antiobody was 
purified from whole serum of rabbits immunized with purified NspS inclusion bodies. Boxes 
surround the 50 kDa heavy chain and the 25 kDa light chain of IgG in the purified antibody 
lane. Whole serum is present in the far right lane. SM-size marker. 
 
Verification of NspS-specificity by the polyclonal anti-NspS antibody 
Purified NspS antibody was then tested for the ability to detect purified NspS protein 
from various V. cholerae periplasmic extracts. Figure 24 shows that periplasmic fractions 
from strains harboring the native chromosomal copy of nspS (357 and 249) produced bands 
at approximately 40 kDa while strains with the recombinant pACYC184::nspS-V5 (AK192) 
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produced a more prominent band at the same region, each of which ran at the same molecular 
weight as purified NspS protein suggesting successful anti-NspS antibody generation. In 
contrast, the 40 kDa band was not detected in a ΔnspS mutant. 
 
 
 
Figure 24: Testing of the polyclonal anti-NspS antibody with periplasmic extracts (peri) 
and pure NspS. Strains 357 and 249 harbor the native chromosomal copy of nspS, AK192 is 
a ∆nspS mutant with the pACYC184::nspS-V5 construct, and ∆nspS is wild-type V. cholerae 
with a chromosomal nspS deletion.  
 
To further test the efficacy of the anti-NspS antibody in the screening procedure 
described above, ELISAs were performed on various cell fractions obtained by sonication or 
use of Bugbuster protein extraction reagent. V. cholerae ΔnspS strains complemented with 
pACYC184::nspS-V5 or vector only were grown to mid-log phase. Anti-NspS antibody was 
added into wells of high affinity microtiter plates to be used as the capture antibody. 
Periplasmic extracts or lysates of a ∆nspS mutant with vector only or complemented with 
wild-type nspS-V5 were prepared and detected using an anti-V5 antibody-HRP conjugate. As 
seen in Figure 25, NspS was detected in all preparations from strains harboring NspS-V5. 
Notably, the periplasmic extract yielded the least amount of nonspecific detection while 
whole cell lysates prepared by sonication or Bugbuster treatment had comparable levels of 
nonspecific binding. Color intensity was at least 3.7-fold greater for strains complemented 
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with wild-type nspS regardless of the treatment, indicating a working system for screening 
against unstable NspS mutants and subsequent interaction experiments.  
 
 
Figure 25: ELISA of wild-type and ΔnspS strain extracts. The bar graph (top) shows 
absorbance intensity at OD450 for periplasmic fractions (white bars), or lysates prepared by 
sonication (grey bars) or bugbuster (black bars) from ∆nspS mutants harboring pACYC184 
plasmid only (∆nspS) or wild-type nspS complement. Wells (bottom) correspond to samples 
in the bar graph above. 
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Discussion 
 
 
 The NspS-MbaA pathway has been shown to play a principal role in mediating V. 
cholerae biofilm formation in response to the polyamines, norspermidine and spermidine 
[47]. This regulation was previously determined to impart such influences on biofilm 
formation via alterations in vps gene transcription through transmission of environmental 
polyamine signals sensed by NspS to MbaA to modulate c-di-GMP PDE activity of the latter 
[47]. Additionally, conserved binding pocket residues in NspS had been shown to alter 
biofilm formation even in the absence of polyamines [82]. However, polyamine 
responsiveness of these mutants remained to be investigated. Moreover, although MbaA has 
been shown to have PDE activity in vitro, the influences of c-di-GMP levels by this protein 
in the context of living cells were unknown [81]. Finally, although preliminary data suggests 
that a direct interaction between NspS and MbaA drives the observed biofilm phenotypes in 
response to specific polyamines, reproducibility of these experiments has been elusive and 
the specific NspS residues involved in mediating this interaction have yet to be identified 
[83].  The main purpose of this study was to thoroughly investigate the mechanisms by which 
NspS and MbaA control biofilm formation in response to norspermidine and spermidine 
from polyamine input through to phenotypic output. 
 While mutation of conserved binding pocket residues in NspS has previously been 
shown to alter V. cholerae biofilm formation, the capacity of these mutants to transmit 
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polyamine signals had not been investigated. Wild-type V. cholerae forms increased biofilms 
in response to norspermidine at levels as low as 10 µM, and forms even more robust biofilms 
in the presence of 100 µM norspermidine [47]. In contrast, the inhibitory effect of spermidine 
on biofilm formation requires levels of around 1 mM. In this study, it was shown that ΔnspS 
deletion complemented with two of three nspS ligand-binding pocket mutants, nspSD170A and 
nspSW261A, were mostly desensitized to norspermidine at 10 µM. However, these mutants 
formed biofilms comparable to a strain complemented with wild-type nspS at norspermidine 
concentrations including 100 µM and 1 mM in both tryptone and LB media, suggesting these 
residues may influence affinity of NspS to norspermidine. On the contrary, these mutant 
strains did not respond to spermidine with a biofilm phenotype, indicating that the 
corresponding aspartate and tryptophan residues may be essential in transmitting spermidine-
specific signals. Alternatively, as the biofilms formed by these mutants in the presence of 
spermidine were similar to that of a ΔnspS mutant, these observations may indicate that the 
influence of MbaA PDE activity is at maximum capacity in the presence of these mutants 
and can have no further detectable reduction on biofilm formation in response to spermidine. 
Interestingly, biofilms formed by a ΔnspS strain complemented with nspSE173A were 
comparable to wild-type when grown in tryptone, and significantly more robust when grown 
in LB. Additionally, this strain did not respond to any concentration of norspermidine tested 
in this study, indicating that this glutamate residue may be required for dose-dependent 
responses to this polyamine when grown in either tryptone or LB. Interestingly, while this 
mutant did not respond significantly to spermidine when grown in LB, biofilms were actually 
increased when grown in tryptone with 100 µM spermidine and decreased back to levels seen 
in media alone at 1000 µM spermidine. The increase in biofilm mass at 100 µM levels may 
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indicate that interactions between spermidine and the Glu173 residue in wild-type NspS 
could be responsible for distinguishing between norspermidine and spermidine as the latter is 
a slightly larger molecule and could thus influence the NspS-MbaA interaction surface by 
pushing against this residue. Therefore, by changing this residue to an alanine, increased free 
space within the binding cleft may compensate for the addition carbon group of spermidine. 
However, an increased sample size would be required to increase confidence in these 
observations particularly considering this observation contrasts with the LB data  vps 
transcription results. It is interesting to note that this strain formed biofilms more robust than 
wild type in LB which is rich in monosaccharides such as glucose, mannose, and galactose, 
but not in tryptone. This observation may indicate that other players involved in the complex 
network of environmental signaling and biofilm formation may additionally influence the 
capacity of NspS and MbaA to modulate this phenotype. That is, perhaps nutrient signals 
have an additive effect on NspS and/or MbaA signaling potential through cooperative 
activity of other periplasmic and/or membrane proteins involved in nutrient sensing and 
transport. 
 As V. cholerae biofilms consist primarily of VPS components, and the effects of 
norspermidine on biofilm formation have been shown to influence vps transcription in a 
NspS-dependent manner, I hypothesized that the biofilm observations made with nspS 
ligand-binding pocket mutants in response to norspermidine or spermidine should be a direct 
result of altered vps transcription in these mutants. In support of this hypothesis, vps activity 
for ΔnspS mutants complemented with nspSD170A or nspSW261A showed reduced vps 
transcription in the absence of polyamines. Furthermore, these mutants showed substantially 
increased vps transcription when grown in the presence of 100 µM norspermidine to levels 
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comparable to wild-type grown under the same conditions, but did not respond to 1 mM 
spermidine. Additionally, the nspSE173A mutant did not respond to either polyamine, further 
corroborating the biofilm data. 
As alteration of NspS ligand-binding pocket residues have drastic effects on vps 
transcription, biofilm formation, and dose-dependent responsiveness to norspermidine and 
spermidine, I hypothesized that the corresponding mutants would have a compromised ability 
to bind these polyamines. Contradictory to this hypothesis, purified NspS ligand-binding 
pocket mutants underwent thermal shifts comparable to that of wild-type protein in the 
presence of all norspermidine and spermidine concentrations tested indicating no significant 
impact on polyamine binding. Notably, the NspSW261A mutant protein alone had a Tm 
approximately 12°C lower than wild-type indicating that the thermal stability of this mutant 
is severely altered. Therefore, although vps transcription and biofilm phenotypes were 
eventually observed for strains expressing the nspSW261A gene with norspermidine addition, 
higher concentrations may be required for maintenance of NspS conformational changes 
which permit signal transduction to MbaA. It has previously been confirmed that all mutants 
express at the same levels as wild-type; therefore, these observations are not due to decreased 
protein levels in the cell [82]. Notably, the first derivative of fluorescence curves did not 
form curves with a single peak, but rather two peaks. This observation may result from 
contaminating protein detected in protein elutions via SDS-PAGE and Coomassie staining. In 
future protein purifications, increasing imidazole concentrations in the resin wash may solve 
the issue of contaminating protein in purified samples. 
It is surprising that, although all mutants showed some diminished capacity to 
transmit norspermidine and spermidine signals, each corresponding purified protein was 
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capable of binding each polyamine. These observations underline the importance of closely 
mimicking the physiological conditions during such experiments. It is possible that 
physiological components of the periplasm may limit or decrease polyamine binding of the 
mutants in vivo such as conformational changes in NspS imparted by interactions with MbaA 
which alter the topology of the binding pocket. However, it also is possible that, although 
polyamine binding is permitted by mutants in the periplasm, transmission of the polyamine 
signal to MbaA is reduced due to alterations in surface topology imparted by such mutations. 
Indeed the uncharged alanine residue is significantly shorter than aspartate, glutamate, and 
tryptophan residues, which, with regards to protein scale, may significantly influence signal 
transmission of signaling proteins. Additionally, the uncharged characteristic differs 
significantly from that of all three amino acids which would be interacting with polyamines 
by ionic interactions (e.g., cation-pi interactions in the case of tryptophan) [88]. It could 
therefore be useful to obtain and compare crystal structures of purified NspS mutants to that 
of wild-type in the presence of relevant polyamines. Finally, it will be necessary to determine 
how these mutants interact with and influence the PDE activity of MbaA in response to 
norspermidine and spermidine. Experiments investigating these aspects of NspS-MbaA 
signaling are currently under way. 
VPS assays corroborate biofilm data and support the hypothesis that modulation of 
PDE activity of MbaA through interactions with NspS influences c-di-GMP levels in the cell, 
as increased levels of this second messenger leads to increases in biofilm formation. It is 
interesting to note that binding pocket residues hypothesized to be involved in polyamine 
binding have such noticeable effects on biofilm formation even in the absence of polyamines. 
Also interesting is the observation that although all three NspS mutants tested were able to 
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bind spermidine and norspermidine, each had unique responses to both polyamines with 
regards to vps transcription and biofilm formation. These findings suggest that while some 
conserved binding pocket residues are required for both norspermidine and spermidine 
signaling, others may be essential for signaling extracellular content of one polyamine or the 
other. Interestingly, although norspermidine is synthesized by V. cholerae, norspermidine is 
not detected in the culture medium, indicating that V. cholerae does not export 
norspermidine; however, many polyamines are acetylated prior to export out of the cell 
(Sanders, Villa, Karatan unpublished) [89]. Our results indicate that norspermidine may also 
undergo chemical modifications prior to export and that this modified norspermidine 
molecule is the more physiologically relevant molecule involved in signaling through NspS. 
Indeed, V. cholerae also contains a homolog of the spermidine N-acetyltransferase from E. 
coli. A recent study screening 95 potential substrates for V. cholerae SpeG showed that 
purified protein interacts with both spermidine and spermine; however, other polyamines, 
specifically norspermidine, were not included in this screen [90]. Therefore, it remains to be 
determined whether this protein has evolved to accommodate norspermidine acetylation, and 
if the acetyl-norspermidine product acts as the true transduction signal in nature. 
 Polyamine signaling through NspS and MbaA is believed to alter vps transcription 
and biofilm formation through modulation of PDE activity and, in turn, c-di-GMP levels in 
the cell. Although MbaA is a confirmed c-di-GMP PDE in vitro, the impact of cellular c-di-
GMP levels through this system had yet to be determined. Using LC-MS/MS analysis of 
cellular c-di-GMP levels for wild-type V. cholerae or a ΔnspS mutant grown in media alone 
or in the presence of norspermidine or spermidine, it was shown that c-di-GMP levels remain 
at about 45-65 nM, regardless of strain or polyamine addition. This indicates that, although 
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polyamine addition has significant effects on vps transcription and biofilm phenotypes, the 
contribution of MbaA PDE activity to cellular c-di-GMP levels is insignificant. This 
observation suggests that the c-di-GMP pool influenced by NspS-MbaA signaling may be 
subcellularly located. Support for high specificity c-di-GMP signaling has recently been 
reported [46]. High specificity c-di-GMP signaling is defined as influencing segregated 
subcellular pools of c-di-GMP to control specific phenotypic outputs. In contrast, low 
specificity systems would influence global pools of c-di-GMP, and c-di-GMP levels would 
remain homogenous throughout the entirety of the cell to control these phenotypic responses. 
Therefore, alterations in biofilm formation would be directly correlated with changes in c-di-
GMP concentrations. It appears that, under the conditions tested, polyamine signaling 
through NspS and MbaA may be subject to high specificity signaling. However, it would be 
interesting in subsequent experiments to compare c-di-GMP levels of a low biofilm forming 
mutant (e.g. ΔnspS) mutant to that of a robust biofilm former such as the same 
overexpressing nspS to determine if more significant influences on global c-di-GMP levels 
may be observed under these conditions. This hypothesis is premised on the observation that 
∆nspS mutants overexpressing wild-type nspS exhibited a 4-fold increase in vps transcription 
as compared to the same harboring vector only. As c-di-GMP influences impacts vps 
transcription, it is possible that overexpression of nspS from the pACYC184 plasmid could 
override the fine-tuning of local c-di-GMP signaling through this system allowing more 
influence of c-di-GMP levels to be observed. 
 In the current model, NspS-MbaA signal transduction requires a direct interaction 
between these proteins, and alterations at the binding interface result in conformational 
changes in MbaA to control PDE activity in response to polyamine binding by NspS. 
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Therefore, once a reproducible experimental design for showing the NspS-MbaA interaction 
is developed, it will be necessary to identify specific residues on both proteins which mediate 
this interaction. However, membrane proteins are notoriously difficult subjects of study due 
to their insoluble nature in aqueous solution. Therefore, a modified approach employing use 
of the periplasmic region of MbaA alone was developed to investigate the nature of this 
interaction. However, under the conditions tested, nonspecific binding of NspS-V5 and 
MbaAp-FLAG to anti-FLAG or anti-V5 agarose beads occurred in co-immunoprecipitation 
experiments. These observations are puzzling and may indicate nonspecific binding to pull-
down antibody linked to the resin, or binding to the resin itself. Future experiments will be 
required to optimize interaction experiments. Alternatively, purified NspS protein may be 
used in ELISA experiments to show the interaction. To this end, the anti-NspS antibody 
would serve as the capture antibody for purified NspS protein. Next, periplasmic extracts of 
strains expressing MbaAp-FLAG would be added and detection with anti-FLAG-HRP 
conjugate would serve to confirm the interaction. However, if nonspecific binding remains an 
issue, periplasmic extracts could be subjected to size exclusion chromatography to obtain 
approximately 29 kDa protein and reduce interaction interference by other components of the 
periplasm and/or nonspecific binding of these other components to NspS.  
Following generation of a consistent model system for showing the NspS-MbaA 
interaction, it will be valuable to delineate the specific residues mediating this interaction in 
both proteins. One approach for defining these residues on NspS would be to use error prone 
PCR or a mutagenesis kit to develop a mutant library for the entirety of the NspS amino acid 
sequence. Mutants would be cloned into an expression vector encoding the V5 epitope tag 
used throughout this study to which a commercially available antibody may be used in 
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immunochemistry experiments. Mutants defective in restoring biofilm formation to a ΔnspS 
mutant would be used in a second screen to identify those which are unstably expressed, have 
mutations within the promoter region thus reducing transcription, or encode premature stop 
codons would be screened for via ELISA. Using an antibody to the vector-encoded epitope, 
as well as the polyclonal anti-NspS antibody generated in this study, elimination of these 
mutants from further screening may be accomplished. A second series of ELISAs may then 
be used with the same polyclonal anti-NspS antibody as the capture antibody for NspS 
mutants. Next, periplasmic extracts of strains expressing mbaAp-FLAG would be added and 
subjected to colorimetric detection using the anti-FLAG-HRP conjugate to identify 
remaining NspS mutants with hindered interactions with MbaA. Sequencing of the remaining 
mutants may then be used to map using homology modeling. Finally, inhibition of the 
interaction may be further confirmed by quantitative chemiluminescent co-
immunoprecipitation experiments. 
In conclusion, this study provides valuable insights into the mechanisms of NspS-
MbaA signaling of environmental polyamines. It was shown that some nspS ligand-binding 
pocket mutants exhibiting diminished vps transcription and biofilm formation have reduced 
sensitivity to norspermidine until higher concentrations are added to culture medium. 
Additionally, these same mutants are unresponsive to spermidine only, while a third mutant 
which exhibits increased biofilm phenotypes is unresponsive to norspermidine, but may have 
acquired to capacity to respond with an increased biofilm phenotype in the presence of 100 
µM spermidine. Surprisingly, all three mutants maintain the capacity to bind both 
polyamines, in vitro. Analysis of c-di-GMP levels indicate that polyamine signaling through 
NspS and MbaA may be a high-specificity system. Finally, several tools for investigating the 
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final piece of this system, the NspS-MbaA interaction, have been developed including a 
periplasmic localization system of the periplasmic region of MbaA, and an anti-NspS 
antibody. Future directions include using these tools in a high through-put immunochemistry-
based screening of a NspS mutant library to identify residues involved in mediation of the 
NspS-MbaA interaction. The plausibility of this approach has been tested through Western 
blotting and ELISAs. As nspS/mbaA gene pairs are widely distributed throughout not only 
Vibrio species, but other more distantly related bacteria, determining surface binding patches 
on these proteins could prove useful for understanding a potentially diverse and novel set of 
signaling protein pairs [81]. Indeed, it is well documented that signaling proteins are 
modular, and the interaction interface involved in mediating NspS-MbaA signaling is thus 
likely employed by other signaling systems aside from that of c-di-GMP modulation [46]. 
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